Media Coverage

Search and Filter
Search by Date Search by Date
Scientific Divisions Scientific Divisions
Results per Page:
  • 5
  • 10
  • 20
  • 50
  • 100
  • all

The mathematics of predicting the course of the coronavirus

Wired reflected on Trevor Bedford’s analysis that by early March COVID-19 had already been circulating in Washington State for weeks. 

Wired
March 30, 2020

As coronavirus spreads, Seattle scientists fast-track potential treatments for COVID-19

Dr. Larry Corey explained how the Seattle scientific community is stepping up to tackle COVID-19. 

The Seattle Times
March 30, 2020

One Seattle party, 8 coronavirus cases: An anatomy of an outbreak

Trevor Bedford’s analysis indicating COVID-19 community transmission had occurred in January is discussed. 

Crosscut
March 30, 2020

The human DNA is littered with fossils of viruses past that attacked us. And lost

Drs. Michael Emerman and Harmit Malik’s work on how they use paleovirology to study viruses, specifically HIV, is discussed. 

The Telegraph India
March 30, 2020

Experts converge on plans for easing coronavirus restrictions safely

The Washington Post discussed a report co-written by Trevor Bedford, outlining steps to guide states through the COVID-19 outbreak. 

The Washington Post
March 29, 2020

Handicapping the future of financial markets

Trevor Bedford is included in a list of scientific resources on COVID-19.

Forbes
March 28, 2020

The other coronavirus test we need

Dr. Jesse Bloom discussed the logistics of developing and using a serological test for the virus causing COVID-19, to determine who has been exposed to the virus. 

Axios
March 28, 2020

Cancer moonshot workshop highlights recent research advances

Dr. Pete Nelson’s recent presentation on new prostate cancer treatment methods is included in a summary of the Cancer Moonshot meeting. 

Cancer Health
March 27, 2020

Not all or nothing: Anti-virus lockdowns could lift slowly

Elizabeth Halloran called for widespread COVID-19 testing as the first step to bring down the pandemic. 

The Associated Press
March 27, 2020

The Seattle scientific community, mobilized

Dr. Kristin Anderson wrote about the researchers in Seattle who are working together to study and combat COVID-19, including Drs. Keith Jerome, Alex Greninger and Trevor Bedford. 

The Timmerman Report
March 27, 2020

March 27: The week in cancer news

Tips for cancer patients in light of COVID-19 from a Fred Hutch news story are included in a weekly round-up. 

Cancer Today
March 27, 2020

‘It isn’t our normal way of working’: Coronavirus outbreak tests limits of remote work in Seattle area

Kelly Crimmins discussed how working remotely has impacted her and her team’s work life and productivity.

The Seattle Times
March 26, 2020

Dr. Julie McElrath on lifting physical distancing measures

Dr. Julie McElrath estimated when the COVID-19 outbreak will reach its peak and when we might see a lift on physical distancing measures. 

KOMO Radio
March 26, 2020

How coronavirus mutations can track its spread—and disprove conspiracies

Trevor Bedford explained how Nextstrain has evolved with open and rapid data sharing, allowing for real time tracking of COVID-19 mutations and spread. 

National Geographic
March 26, 2020

Dr. Julie McElrath on COVID-19 vaccines

Dr. Julie McElrath discussed potential COVID-19 vaccine options and programs. 

KOMO Radio
March 26, 2020

The U.S. now has more confirmed coronavirus cases than anywhere else in the world

Vox mentioned Trevor Bedford’s U.S. COVID-19 infection estimates and research on the spread of the virus.

Vox
March 26, 2020

Cancer consortium launches COVID-19 registry in urgent appeal for data to save lives at risk from infection

Dr. Gary Lyman commented on the new COVID-19 and Cancer Consortium (CCC19) registry and how they will use COVID-19 data to inform treatment. 

ASCO Daily News
March 26, 2020

How does the coronavirus behave inside a patient?

Dr. Joshua Schiffer and Bryan Mayer discussed viral load variability in patients and what that could mean for COVID-19. 

The New Yorker
March 26, 2020

Dr. Tom Lynch on COVID-19 challenges

Dr. Tom Lynch described the challenges of testing and accurately reporting COVID-19 in a Fred Hutch town hall. 

KOMO Radio
March 26, 2020

Eerily on the mark, a gene detective's coronavirus findings raise hope and fear in equal measure

The Nextstrain project and Trevor Bedford’s analyses on COVID-19 are explained. 

Economic Times India
March 26, 2020

How ASH supports the hematology community during COVID-19, with Drs. Stephanie Lee & Laura Michaelis

Dr. Stephanie Lee spoke about COVID-19 and hematology, and how ASH is supporting the community.  

The Hematologist
March 25, 2020

The coronavirus is mutating. But that may not be a problem for humans

Trevor Bedford commented on the implications of COVID-19’s slow mutation rates, suggesting it will lead to immunity after exposure. 

NPR
March 25, 2020

The coronavirus mutates more slowly than the flu — which means a vaccine will likely be effective long-term

Trevor Bedford’s comments on the mutation patterns of COVID-19 and how that impacts vaccine production are cited. 

Business Insider
March 25, 2020

COVID-19 poses special challenges to cancer care

Drs. Steve Pergam and Masumi Ueda gave expert advice on treating cancer patients during the COVID-19 pandemic.

MedPage Today
March 25, 2020

The blind leading the blind: COVID-19, cancer, and the need for more data

Dr. Gary Lyman discussed best practices for treating cancer patients during the COVID-19 outbreak.

ASCO Daily News
March 25, 2020

Fred Hutch researcher: ‘We need facts from experts’ in coronavirus briefings

Dr. Steve Pergam called for more scientific involvement in decisions around COVID-19 containment. 

My Northwest
March 24, 2020

Some cancer patients face delayed surgeries and scaled-back treatments as the coronavirus advances

Dr. Nancy E. Davidson discussed how cancer patient treatment has evolved in light of COVID-19.

The Washington Post
March 24, 2020

Seattle coronavirus assessment network launches with boost from Bill Gates, Amazon and volunteers

The new SCAN initiative is profiled, mentioning Fred Hutch as one of the founding partners. 

GeekWire
March 23, 2020

A virologist answers your questions about coronavirus

Jesse Bloom answered questions from community members on COVID-19 and the current status of COVID-19 research.  

KUOW
March 23, 2020

Cancer care and COVID-19 in Seattle, the first U.S. epicenter

Dr. Masumi Ueda explained how Fred Hutch’s clinical care partner Seattle Cancer Care Alliance approached COVID-19 prevention and identification in clinics and workspaces.  

Medscape
March 23, 2020

How long will the outbreak last? It depends on what we do now

Trevor Bedford is quoted on ideas to tackle the COVID-19 pandemic through social distancing and extensive testing. 

Wired
March 23, 2020

The coronavirus testing paradox

Trevor Bedford’s tweets on suggested strategies to curb the COVID-19 pandemic are quoted, specifically on the need for increased testing and social distancing. 

ProPublica
March 23, 2020

Amazon will deliver and pick up test kits being issued by a new coronavirus program in Seattle

Fred Hutch is listed among other partners involved in the new SCAN program to test for COVID-19 across Seattle, through mailed test kits. 

CNBC
March 23, 2020

When will the coronavirus pandemic end? What scientists can say about life returning to normal

Dr. Elizabeth Halloran reinforced the need for COVID-19 testing to control the pandemic.

The Boston Globe
March 21, 2020

How the virus got out

Trevor Bedford and Dr. Elizabeth Halloran provided expertise for this interactive COVID-19 map, which overlays travel and migration data with epidemiological data. 

The New York Times
March 21, 2020

How the coronavirus became an American catastrophe

The Atlantic described Trevor Bedford’s work in discovering COVID-19 had spread in Washington to his recommendations for slowing the pandemic.

The Atlantic
March 21, 2020

The 9 most important unanswered questions about COVID-19

Trevor Bedford commented on U.S. COVID-19 infection rates, providing estimates between 10,000 – 40,000. 

Vox
March 20, 2020

How to navigate cancer in the wake of the COVID-19 pandemic

Dr. Steve Pergam gave insight on the risk of cancer patients for COVID-19 infection. 

CURE Today
March 20, 2020

Study suggests COVID-19 might follow seasonal pattern

Dr. Elizabeth Halloran provides context to COVID-19 transmission rates and spread. 

U.S. News and World Report
March 19, 2020

How genetic mapping is allowing scientists to track the spread of coronavirus

Trevor Bedford and Jesse Bloom gave context to how they used genomic analysis of COVID-19 to track its spread.

NPR
March 19, 2020

How long will Americans be fighting the coronavirus?

Dr. Elizabeth Halloran explained community transmission and how it can lead to an epidemic in reference to COVID-19. 

The Associated Press
March 19, 2020

The danger of a second wave

Trevor Bedford’s methods for stopping the COVID-19 outbreak are outlined, including isolating the infected, and having those who are recovered return to work. 

The Washington Post
March 19, 2020

Covid-19 roundup: Fred Hutch cuts down further on lab work, Roche joins Regeneron and Sanofi in IL-6 trials, China orders a vaccine effort

Fred Hutch is included in a round up of COVID-19 updates across cancer and biotechnology companies. 

Endpoints News
March 19, 2020

In hard-hit Seattle, coronavirus pushes biotechs to a new normal

Hilary Hehman discussed how Fred Hutch is continuing research and supporting partnerships during the COVID-19 pandemic. 

BioPharma Dive
March 19, 2020

Coronavirus sleuth outlines his ‘Apollo program’ for bringing down the pandemic

Trevor Bedford commented on a new modeling report, suggesting how social distancing measures and testing can stop the COVID-19 pandemic. 

GeekWire
March 18, 2020

Mild cases may be driving coronavirus spread

WebMD discussed Dr. Elizabeth Halloran’s Science paper on COVID-19 modeling and preventative measures to limit transmission. 

WebMD
March 17, 2020

How South Korea scaled coronavirus testing while the U.S. fell dangerously behind

Trevor Bedford commented on the Ohio COVID-19 infection numbers, suggesting they are overestimated. 

ProPublica
March 17, 2020

Why social distancing is so hard – and so important

Dr. Steve Pergam provided crucial advice on social distancing and the role it plays in preventing COVID-19 spread.  

Q13 FOX News
March 17, 2020

11 things everyone should know about getting the novel coronavirus

Vox mentioned Trevor Bedford’s estimates that there are around 20,000 COVID-19 cases across the U.S. to date.  

Vox
March 16, 2020

Coronavirus is hiding in plain sight

Dr. Elizabeth Halloran, an infectious disease expert, provided commentary on the need for widespread COVID-19 testing.

The New York Times
March 16, 2020

Over 85% of COVID-19 infections in China went undetected early on

Dr. Elizabeth Halloran reinforced the importance of testing and social distancing to lower COVID-19 transmission.

MedPage Today
March 16, 2020

COVID-19 and cancer

Dr. Steve Pergam gave Healio in depth advice to cancer patients to protect themselves from COVID-19.

Healio
March 16, 2020

Why Washington state is at the center of the US coronavirus outbreak

Dr. Keith Jerome’s COVID-19 test kit and the development of UW’s testing facilities are discussed. 

The Guardian
March 16, 2020

'Invisible enemy'

Politico referenced Trevor Bedford’s estimate that there are between 10,000 – 40,000 U.S. COVID-19 cases.

Politico
March 16, 2020

Coronavirus: Infected people without symptoms are driving epidemic’s fast spread

Dr. Elizabeth Halloran stressed the importance of wide-spread testing to slow the spread of COVID-19.

San Jose Mercury News
March 16, 2020

Scott Gottlieb discusses coronavirus on 'Face the Nation' March 15, 2020

Trevor Bedford’s commented on COVID-19 infection rate estimates across the U.S. are considered.

CBS News
March 15, 2020

How it spreads, infects: Coronavirus impact comes into focus

The Associated Press explored if reinfection is possible, referencing research on COVID-19 mutation rates from Fred Hutch. 

The Associated Press
March 15, 2020

Can people who recover from COVID-19 become reinfected?

Snopes referenced Fred Hutch research on mutation rates of COVID-19 in relation to the possibility of reinfection.

Snopes
March 15, 2020

Seattle expert estimates 20,000 novel coronavirus infections in the U.S. now

Trevor Bedford’s estimates of U.S. COVID-19 infection rates are mentioned in light of new outbreaks.

The Seattle Times
March 14, 2020

Coronavirus hot zone: Research and responses in the U.S. epicenter

Dr. Steve Pergam is interviewed on COVID-19 and the risk to immunocompromised people. 

Scientific American
March 14, 2020

The etiquette of social distancing in the time of coronavirus, from the ‘Miss Manners’ of germs

Dr. Steve Pergam, an infectious disease expert, provided commentary on social distancing in light of COVID-19. 

The Seattle Times
March 14, 2020

Trump is banning travelers from the UK to combat coronavirus. Domestic travel restrictions could come next

Trevor Bedford’s research suggesting most new COVID-19 cases are due to community transmission rather than travel is highlighted. 

Vox
March 14, 2020

Flu watchdog spots more with fever and cough, but it’s not flu

Trevor Bedford’s tweets on transmission chains leading to COVID-19 outbreaks across the U.S. are mentioned. 

Bloomberg
March 14, 2020

Mapping the social network of coronavirus

Betz Halloran commented on the power of data science and modeling to track COVID-19 and other viruses.

The New York Times
March 13, 2020

COVID-19 can’t spread if you stay home

A modeling study from Fred Hutch is cited on results suggesting Seattle two weeks ago was approximately in the position of Wuhan, China, on Jan. 1.

The Wall Street Journal
March 13, 2020

Is your cancer center ready for COVID-19?

Dr. Steve Pergam provided expert commentary for cancer patients in light of COVID-19 and increased risk. 

The Cancer Letter
March 13, 2020

Efforts to control coronavirus could get even more extreme

Results from a preliminary paper indicating that social distancing is effective at lowering disease spread by Trevor Bedford and colleagues is mentioned.

The New York Times
March 13, 2020

Microbiome predicts blood-cell transplant success

David Fredricks commented on outcomes of a large, international study showing that the microbiome predicts transplant success.  

Cancer Discovery
March 13, 2020

Data sharing and open source software help combat COVID-19

Open data sharing and the use of Nextstrain by Trevor Bedford and colleagues to track COVID-19 is discussed.

Wired
March 13, 2020

How much is coronavirus spreading under the radar?

Trevor Bedford’s discovery of community transmission of COVID-19 in Washington is referenced.

Nature
March 13, 2020

Cancelations and rising confusion: This week’s coronavirus news

Trevor Bedford is included in a list of COVID-19 experts. 

Undark
March 13, 2020

Coronavirus is already here. Blocking travelers won’t prevent its spread.

Vox referenced Trevor Bedford’s analysis on the impact of travel bans to prevent COVID-19 spread.

Vox
March 12, 2020

Without ‘social distancing,’ 400 could die from coronavirus in Western Washington by April 7, study suggests

Results from a preliminary paper indicating that social distancing is effective at lowering disease spread by Trevor Bedford and colleagues is mentioned. 

The Seattle Times
March 12, 2020

Local efforts are much more important than travel bans to stop the spread of infection

Dr. Elizabeth Halloran discussed her Science study showing how travel bans slowed but did not stop the spread of COVID-19.

Dagens Nyheter
March 12, 2020

FOX News Rundown

Dr. Jesse Bloom explained COVID-19 and its spread from his point of view as a virologist. 

FOX News
March 12, 2020

Sports provide a refuge, but they blurred our vision on coronavirus

A study by Trevor Bedford and colleagues predicting infection rates is referenced in light of new social distancing measures. 

The Washington Post
March 12, 2020

Researcher says more coronavirus testing will help manage outbreak, but travel bans? Not so much

Trevor Bedford’s analysis on infection rates and the efficacy of travel bans to lower COVID-19 transmission is discussed. 

GeekWire
March 12, 2020

Scientist links 2 state outbreaks with genetic fingerprints

Trevor Bedford explained his analysis of  the transmission pathway of COVID-19 throughout Washington, likely beginning with one person. 

The Associated Press
March 11, 2020

Merkel gives Germans a hard truth about the coronavirus

Infectious disease expert Betz Halloran provided global infection rate estimates based on her research. 

The New York Times
March 11, 2020

Please, listen to experts about the coronavirus. Then step up.

Trevor Bedford is referenced for his research suggesting a larger outbreak in Washington than testing has reflected. 

The New York Times
March 11, 2020

AP source: Inslee to ban large gatherings in Seattle area

Trevor Bedford’s research with Seattle Flu Study is referenced as support for new social distancing measures. 

The Associated Press
March 11, 2020

“The nature of viruses is to mutate”: Mapping the spread of a deadly disease

Vanity Fair profiled Trevor Bedford and Nextstrain collaborators, referencing tracking COVID-19, genomic analysis and transmission rates.  

Vanity Fair
March 11, 2020

Why older and chronically ill Americans are at greatest risk from coronavirus

Dr. Steve Pergam comments on COVID-19 risk for cancer patients. 

The Washington Post
March 10, 2020

How does one Seattle coronavirus patient turn into two six weeks later?

Massive Science delves into how COVID-19 spread without detection, referencing Trevor Bedford’s detailed genetic analysis of community transmission. 

Massive Science
March 10, 2020

Cancer patients and coronavirus: Here's everything to know

Dr. Steve Pergam is quoted on his advice for cancer patients in light of increased risk for COVID-19. 

International Business Times
March 10, 2020

How to cope with Seattle’s coronavirus outbreak? Pretend that you’re snowed in

GeekWire discussed social distancing in light of Trevor Bedford’s COVID-19 transmission predictions. 

GeekWire
March 10, 2020

Italy’s coronavirus crisis could be America’s

 Trevor Bedford is quoted among other Nextstrain collaborators on their COVID-19 analysis, in light of Italy's outbreak. 

Vox
March 10, 2020

Mutations can reveal how the coronavirus moves—but they’re easy to overinterpret

Trevor Bedford’s genetic analysis on the spread of COVID-19 into Italy and the spread across Washington State is considered. 

Science
March 09, 2020

Seattle’s patient zero spread coronavirus despite ebola-style lockdown

Bloomberg followed the Washington COVID-19 outbreak, including Trevor Bedford’s discovery of community transmission and subsequent genetic analysis of the spread. 

Bloomberg Businessweek
March 09, 2020

Coronavirus mismanagement is risking American lives

Fred Hutch and Trevor Bedford’s modeling results suggesting undetected COVID-19 are cited in a commentary about COVID-19 spread.  

Forbes
March 09, 2020

Gates Foundation to deliver at-home coronavirus test kits, additional funding to Seattle

Fred Hutch is mentioned as one of the institutions supporting Seattle Flu Study.

GeekWire
March 08, 2020

Coronavirus: A disease that thrives on human error

Trevor Bedford is quoted on his research on missed transmission pathways of COVID-19.

The Guardian
March 07, 2020

The official coronavirus numbers are wrong, and everyone knows it

Trevor Bedford’s data indicating untracked COVID-19 spread in Washington State is referenced. 

The Atlantic
March 07, 2020

Study says travel restrictions can delay, but can’t defeat a global coronavirus outbreak

Biostatistician Elizabeth Halloran’s research on the role of travel restrictions in delaying COVID-19 spread is discussed. 

GeekWire
March 06, 2020

I live in Kirkland, epicenter of the US outbreak. We need Trump to take this seriously

Fred Hutch research on COVID-19 community transmission rates in Kirkland, Washington is mentioned.

CNN
March 06, 2020

Coronavirus vs. oncology: Meeting cancellations, travel restrictions, fears about drug supply chain

The Cancer Letter includes Fred Hutch’s remote work policy in a list of updates related to COVID-19. 

The Cancer Letter
March 06, 2020

Fred Hutch mandates remote working to curb COVID-19

FierceBiotech profiled Fred Hutch for COVID-19 remote work policies and for Trevor Bedford’s COVID-19 research.  

FierceBiotech
March 06, 2020

Some good coronavirus news: genetic detectives are on the case

Computational biologist Trevor Bedford explained how researchers are using Nextstrain and genetic analysis techniques to track COVID-19 in real time. 

The Boston Globe
March 06, 2020

Seattle's critical coronavirus test

Gates Foundation funding of COVID-19 research, including Fred Hutch and Seattle Flu Study, is mentioned.

The Seattle Times
March 06, 2020

Scientists say coronavirus mutations aren’t more deadly or contagious

Computational biologist Trevor Bedford discussed how he has been using Nextstrain to understand COVID-19 genetics and spread. 

Wall Street Journal
March 06, 2020

The race to unravel the United States’ biggest coronavirus outbreak

Seattle Flu Study is profiled, delving into Drs. Keith Jerome, Helen Chu and Trevor Bedford’s research on COVID19 genetic analysis and vaccine development. 

Nature
March 06, 2020

Software and genetic sequencing track the coronavirus's path

Trevor Bedford’s research using the Nextstrain platform is explored, specifically its role in real time tracking of COVID-19.

IEEE Spectrum
March 06, 2020

Coronavirus in the US: Tracking cases and deaths

Trevor Bedford's research suggesting under detection of COVID-19 cases in Washington State is mentioned.

Vox
March 06, 2020

Exclusive: The strongest evidence yet that America is botching coronavirus testing

Virologist Dr. Keith Jerome’s COVID-19 testing kit is discussed, along with Trevor Bedford’s computational analysis of COVID-19 spread. 

The Atlantic
March 06, 2020

Fred Hutchinson Center initiates mandatory work-from-home policy as outbreak roils businesses, conferences

Fred Hutch’s work from home policy is mentioned, among other local organizations, as a response to the COVID-19 outbreak in Washington State.

Endpoints News
March 05, 2020

In the age of coronavirus, our nation needs a responsible leader who trusts scientists

Trevor Bedford explains how a lack of testing allowed COVID-19 to spread undetected in Washington State. 

The Seattle Times
March 05, 2020

Why Washington State? How did it start? Questions answered on the U.S. coronavirus outbreak

Trevor Bedford’s work on the spread and genetic variation of COVID-19 from China to the US is discussed. 

The New York Times
March 05, 2020

Washington coronavirus update: Pence heads to state amid outbreak as school close, companies’ employees told to work remotely and more

Fred Hutch is included in a summary of coronavirus updates about Washington State, for the implementation of the work from home policy. 

Newsweek
March 05, 2020

Microsoft, Amazon and other tech firms urge employees to work from home to slow spread of coronavirus

Fred Hutch’s work from home policy is mentioned, among other local organizations, as a response to the COVID-19 outbreak in Washington State. 

The Seattle Times
March 04, 2020

Coronavirus Live Updates: The latest COVID-19 developments in Seattle and the world of tech

Fred Hutch is included in a round up of Seattle tech companies implementing work policy changes in response to COVID-19. 

GeekWire
March 04, 2020

The coronavirus is exposing another disease we need to cure, stat

A columnist referenced computational biologist Trevor Bedford and his blog content on COVID-19 projected spread and recommendations.

The Seattle Times
March 04, 2020

Response in China slowed outbreak of coronavirus — but experts caution against extreme measures in Seattle

Fred Hutch and computational biologist Trevor Bedford are referenced on the COVID-19 outbreak and preventative measures cities are taking to slow the spread of the virus. 

The Seattle Times
March 04, 2020

Feds investigate nursing home as U.S. death toll hits 11

Fred Hutch is cited as one the organizations implementing social distancing policies as a result of the COVID-19 outbreak in Washington State. 

Associated Press
March 04, 2020

UW Medicine ramps up new coronavirus lab test; Gates Foundation pledges $5M for detection

The Seattle Flu study is discussed, including Fred Hutch’s role in the project, as part of the release of a new testing kit for COVID-19. 

The Seattle Times
March 04, 2020

UW Medicine gets green light to test for coronavirus

Dr. Keith Jerome, a virologist, provided commentary on his new COVID-19 testing kit at UW Medicine. 

The Seattle Times
March 04, 2020

Column: COVID-19 could kill the for-profit science publishing model. That would be a good thing

The rapid data sharing involved in Trevor Bedford’s work is discussed as an example of open science.  

Los Angeles Times
March 03, 2020

Inside the work being done to conquer blood diseases

Dr. Stephanie Lee explained the work of hematologists and the role of ASH in moving hematology forward. 

Future of Personal Health
March 03, 2020

Washington State risks seeing explosion in coronavirus cases without dramatic action, new analysis says

Computational biologist Trevor Bedford explained his analysis on COVID-19 spread and provided recommendations for the greater Seattle area. 

STAT
March 03, 2020

What people with HIV need to know about the new coronavirus

Infectious disease expert Dr. Steve Pergam comments on what people with HIV need to know about COVID-19

Poz
March 02, 2020

Authorities announce 2nd coronavirus death in US

Trevor Bedford, a computational biologist, is quoted on his COVID-19 genetic analysis. 

Associated Press
March 02, 2020

Coronavirus may have spread in Washington state for weeks, according to study

Computational biologist Trevor Bedford and his research on the Washington COVID-19 outbreak is discussed.

Slate
March 02, 2020

New coronavirus cases in Western Washington are likely doubling every 6 days, Fred Hutch scientist says

Trevor Bedford, a computational biologist, provided expert commentary on the infection rates and genetic analysis of COVID-19.

The Seattle Times
March 02, 2020

What people with cancer need to know about the new coronavirus

Dr. Steve Pergam, an infectious disease expert, provided insight on COVID-19 risk for cancer patients.

Cancer Health
March 02, 2020

Genetic analysis suggests coronavirus infections double every six days, spreading to hundreds

Computational biologist Trevor Bedford discussed his analysis providing COVID-19 infection estimates for Washington state

GeekWire
March 02, 2020

A dire phase of the coronavirus outbreak? ‘Boom’ of US cases ‘should be expected’ as global death toll tops 3,000

Trevor Bedford, a computational biologist, is quoted on the COVID-19 spread and genetic analysis.

USA Today
March 02, 2020

A second person in the U.S. – and King County – dies of novel coronavirus; more cases likely

Computational biologist Trevor Bedford is quoted on COVID-19 transmission in Seattle. 

The Seattle Times
March 01, 2020

Coronavirus may have spread in U.S. for weeks, gene sequencing suggests

Computational biologist Trevor Bedford is quoted on the COVID-19 outbreak in Seattle.

The New York Times
March 01, 2020

As testing quickly ramps up, expect more U.S. coronavirus cases

Trevor Bedford, a computational biologist, is mentioned in reference to COVID-19 genetic analysis and spread in Washington. 

NPR
March 01, 2020

Scott Gottlieb “Face the Nation”

Computational biologist Trevor Bedford and Fred Hutch are mentioned in reference to the COVID-19 outbreak and genetic analysis. 

CBS News
March 01, 2020

No, the coronavirus was not genetically engineered in a Wuhan lab, expert says

Trevor Bedford, a computational biologist, provided expert commentary on the origins of COVID-19. 

Financial Times (via MSN News)
February 14, 2020

Here’s how computer models simulate the future spread of new coronavirus

Elizabeth Halloran, an infectious disease expert, discussed modeling and projections for COVID-19’s spread. 

Scientific American
February 13, 2020

'We're opening everything': Scientists share coronavirus data in unprecedented way to contain, treat disease

Trevor Bedford, a computational biologist, shared his thoughts on how open data sharing has aided real-time tracking of COVID-19. 

CBC News
February 01, 2020

Mining coronavirus genomes for clues to the outbreak’s origins

Trevor Bedford, a computational biologist, discussed COVID-19 and his research on the virus’ genome.  

Science Magazine
January 31, 2020

Robot is helping to treat man with coronavirus in special isolation room at hospital north of Seattle

Computational biologist Trevor Bedford’s research on COVID-19 is mentioned in reference to a patient in Everett, Washington. 

GeekWire
January 27, 2020

Containing new coronavirus may not be feasible, experts say, as they warn of possible sustained global spread

Computational biologist Trevor Bedford discussed projections for the spread of COVID-19.

STAT News
January 26, 2020

Scientists race to find out how Wuhan victims became ill

Trevor Bedford, a computational biologist, provided expert commentary on COVID-19. 

The Guardian
January 25, 2020

New virus paralyzes Chinese cities

Computational biologist Trevor Bedford discussed COVID-19. 

NPR Science Friday
January 24, 2020

Could China's new coronavirus become a global epidemic?

Trevor Bedford, a computational biologist, discussed his analysis of COVID-19 genomes.

Wired
January 22, 2020

China coronavirus: Six questions scientists are asking

Computational biologist Trevor Bedford provided expert commentary on COVID-19. 

Nature
January 22, 2020

Ex-Bristol R&D Chief to helm Seattle cancer center

 Dr. Thomas J. Lynch shared some of his top goals for Fred Hutch as its incoming president and director. 

The Wall Street Journal
January 07, 2020

Scientists link mysterious snippets of DNA to cell growth and tumor suppresion

Dr. Rob Bradley discussed the importance of poison exons and tumor suppression. 

GeekWire
January 07, 2020

Taking supplements during breast cancer treatment increase risk of death and relapse, what does this mean for patients?

Dr. Kevin Cheung provided expert commentary on the relationship between breast cancer and nutritional supplements. 

Forbes
January 06, 2020

Leaving the reservation for higher education: The story of two brothers

Great Falls Tribune profiled Josh Marceau and his path to Fred Hutch.  

Great Falls Tribune
January 02, 2020

CAR T-cell therapy in pediatric ALL

OncLive featured Dr. David Maloney in a panel on CAR T-cell therapies for pediatric ALL. 

OncLive
December 23, 2019

Barbie puts on a lab coat and finds formula to win holiday diorama contest at Seattle’s Fred Hutch

Graeme Black of Fred Hutch’s immunology program commented on the idea behind his “Winterfest” diorama contest entry.   

GeekWire
December 20, 2019

Now & then: Grown-up Joey Hutchinson’s fire is ‘all part of the legacy’

Joey Hutchinson, grandson of Fred Hutchinson, discussed his family’s legacy.

The Seattle Times
December 20, 2019

How one common immune cell prevents checkpoint inhibitors from attacking cancer

FierceBiotech covered Dr. McGarry Houghton’s study on neutrophils and checkpoint inhibitors.

FierceBiotech
December 20, 2019

Fred Hutchinson is researching new cancer treatments in the cloud with AWS

Dr. Raphael Gottardo discussed how machine learning can help his work in immunotherapy research. 

Diginomica
December 18, 2019

Don’t call me Karen, Cheryl, Nancy, Reshma, Cornelia, Caryn, Sharon, …call me “Doctor”.

Dr. Nancy Davidson shared  her experiences with gender bias in oncology.  

The Cancer Letter
December 13, 2019

Thin metal films loaded with immune cells show promise as cancer therapy

Dr. Matthias Stephan commented on his research on CAR T-cell delivery systems. 

GeekWire
December 09, 2019

Why didn’t we hatch from eggs? Thank viruses, says biologist

Dr. Harmit Malik discussed his research on retroviruses. 

KNKX
December 07, 2019

Gary Gilliland: Seattle has ‘extraordinary potential’ to be a leader in cancer research

Dr. Gary Gilliland shared his views on the future of Fred Hutch. 

Puget Sound Business Journal
December 06, 2019

A new study says hair dyes and chemical straighteners may cause cancer

Dr. Anne McTiernan provided expert commentary on the relationship between hair dyes and cancer.

Forbes
December 04, 2019

An HIV vaccine by 2021? Here is what needs to happen

Forbes detailed the current status of HIV trials, including those conducted by the HIV Vaccine Trials Network, which is headquartered at Fred Hutch.

Forbes
December 03, 2019

Cancer sends many patients into bankruptcy. Advisors are stepping up to stop that

Dr. Veena Shankaran shared her insights about the financial burden of cancer care. 

CNBC
November 24, 2019

Lung-MAP trial reveals genetic testing knowledge gaps among patients

Dr. Joshua Roth discussed his study on genetic testing knowledge.

Cure Today
November 20, 2019

Melanoma rates falling sharply among teens and young adults, UW study finds

KOMO News covered a recent study between Fred Hutch and UW researchers that found that melanoma rates are decreasing in young adults. 

KOMO News
November 13, 2019

Lung cancer rates among women are falling much slower than those in men. Here’s why

Dr. Alice Berger commented on the possible roles of genetics in lung cancer prevalence among women who do not smoke. 

TIME
November 07, 2019

Denise Galloway helped pave the way for the HPV vaccine

Dr. Denise Galloway shared some career highlights as part of winning a 2019 Women of Influence Award.

Puget Sound Business Journal
November 07, 2019

From cancer patient to medical crusader: Fred Hutch researcher shares her journey

Dr. Kristin Anderson shared her personal story about what led her to study immunology in ovarian cancer.

King 5 News
November 06, 2019

How clinical trials are leading to breakthroughs in cancer treatments

Dr. Damian Green discussed the importance of clinical trials. 

King 5 News
November 05, 2019

Hormone therapy for breast cancer

Dr. Hannah M. Linden provided expert commentary on hormone therapy. 

U.S News & World Report
November 04, 2019

How Washington keeps America sick and fat

Dr. Mario Kratz commented on clinical nutrition research funding.

Politico
November 04, 2019

The Health 202: cancer patients have steep expenses beyond treatment. This rock band is trying to help.

Washington Post Dr. Anne McTiernan provided expert commentary on cancer risk factors. 

Washington Post
October 18, 2019

The Health 202: cancer patients have steep expenses beyond treatment. This rock band is trying to help.

Washington Post Dr. Anne McTiernan provided expert commentary on cancer risk factors. 

Washington Post
October 18, 2019

Vaginal fluid transplants hold promise but raise safety concerns

Dr. David Fredricks, a microbiome researcher, provided expert commentary on vaginal microbiota transplantation.

Scientific American
October 16, 2019

Vaginal fluid transplants hold promise but raise safety concerns

Dr. David Fredricks, a microbiome researcher, provided expert commentary on vaginal microbiota transplantation.

Scientific American
October 16, 2019

Fred Hutch scientists on how gold nanoparticles could bring CRISPR to the developing world

GeekWire featured Dr. Jennifer Adair’s research on CRISPR and gold nanoparticles.

GeekWire
October 10, 2019

Fred Hutch scientists on how gold nanoparticles could bring CRISPR to the developing world

GeekWire featured Dr. Jennifer Adair’s research on CRISPR and gold nanoparticles.

GeekWire
October 10, 2019

ElevateBio founds HighPassBio to develop Fred Hutch cell therapy

FierceBiotech highlighted new spinout HighPassBio, founded by Hutch researcher Marie Bleakley.

FierceBiotech
October 01, 2019

Seattle researchers seeking volunteers for breast cancer study

KING 5 highlighted a current study led by Dr. Anne McTiernan looking at the effects of exercise on breast cancer.

KING 5
October 01, 2019

Why the women most likely to die of breast cancer have gotten the least attention

Time included expert commentary from Dr. Cyrus Ghajar on metastatic breast cancer.

Time
October 01, 2019

Why the women most likely to die of breast cancer have gotten the least attention

TIME included expert commentary from Dr. Cyrus Ghajar on metastatic breast cancer.

Time
October 01, 2019

ElevateBio founds HighPassBio to develop Fred Hutch cell therapy

FierceBiotech highlighted new spinout HighPassBio, founded by Hutch researcher Marie Bleakley.

FierceBiotech
October 01, 2019

Seattle researchers seeking volunteers for breast cancer study

KING 5 highlighed a current study led by Dr. Anne McTiernan looking at the effects of exercise on breast cancer.

KING 5
October 01, 2019

Gift to Fred Hutchinson Cancer Research Center fueling push to cure pediatric cancer

KIRO 7 featured Fred Hutch’s efforts in pediatric cancer research.

KIRO 7
September 25, 2019

GeekWire Summit: Health tech innovators to discuss gene editing; AI; telemedicine; and more

GeekWire highlighted Dr. Jennifer Adair’s talk on gene editing at the GeekWire Summit.

GeekWire
September 25, 2019

Milestones in Medicine: How Immunotherapy Began in Cancer Care

Cure featured Dr. Phil Greenberg’s research on T-cell receptor therapies. 

Cure
September 25, 2019

GeekWire Summit: Health tech innovators to discuss gene editing; AI; telemedicine; and more

GeekWire highlighted Dr. Jennifer Adair’s talk on gene editing at the GeekWire Summit.

GeekWire
September 25, 2019

Milestones in Medicine: How Immunotherapy Began in Cancer Care

Cure featured Dr. Phil Greenberg’s research on T-cell receptor therapies. 

Cure
September 25, 2019

Gift to Fred Hutchinson Cancer Research Center fueling push to cure pediatric cancer

KIRO 7 featured Fred Hutch’s efforts in pediatric cancer research.

KIRO 7
September 25, 2019

Dr. Lyman on challenges with biosimilar policies

 Dr. Gary Lyman, senior lead of health care quality and policy at Fred Hutch, provided expert commentary on biosimilar policies.

OncLive
September 24, 2019

Dr. Lyman on challenges with biosimilar policies

 Dr. Gary Lyman, senior lead of health care quality and policy at Fred Hutch, provided expert commentary on biosimilar policies.

OncLive
September 24, 2019

HIV vaccine shows signs of cross-subtype protection

FierceBiotech featured a Fred Hutch study suggesting cross-subtype immune response against HIV in South Africa.

FierceBiotech
September 20, 2019

HIV vaccine shows signs of cross-subtype protection

FierceBiotech featured a Fred Hutch study suggesting cross-subtype immune response against HIV in South Africa.

FierceBiotech
September 20, 2019

Life after surviving cancer: the relief, challenges, and new fears

KUOW hosted Laura Landro, WSJ contributor, who discusses her treatment at Fred Hutch.  

KUOW
September 19, 2019

Life after surviving cancer: the relief, challenges, and new fears

KUOW hosted Laura Landro, WSJ contributor, who discusses her treatment at Fred Hutch.  

KUOW
September 19, 2019

Fred Hutch President Gary Gilliland to step down as leader of cancer research powerhouse

GeekWire featured President Gary Gilliland’s statement on stepping down from his role at Fred Hutch.  

GeekWire
September 17, 2019

Dr. Grivas on biomarker for Pembrolizumab response in urothelial cancer

OncLive highlighted Dr. Petros Grivas and his work on urothelial cancer. 

OncLive
September 17, 2019

Dr. Grivas on biomarker for Pembrolizumab response in urothelial cancer

OncLive highlighted Dr. Petros Grivas and his work on urothelial cancer. 

OncLive
September 17, 2019

Fred Hutch President Gary Gilliland to step down as leader of cancer research powerhouse

GeekWire featured President Gary Gilliland’s statement on stepping down from his role at Fred Hutch.  

GeekWire
September 17, 2019

A Patient’s Guide to Acute Lymphoblastic Leukemia

Dr. Ryan Cassaday shared his expertise on Acute Lymphoblastic Leukemia.

U.S. News & World Report
September 09, 2019

Reducing the risk of blood clots in patients with Multiple Myeloma

Cure Today featured Dr. Ang Li’s paper on risk factors for patients with Multiple Myeloma.

Cure Today
September 09, 2019

A Patient’s Guide to Acute Lymphoblastic Leukemia

Dr. Ryan Cassaday shared his expertise on Acute Lymphoblastic Leukemia.

U.S. News & World Report
September 09, 2019

Reducing the risk of blood clots in patients with Multiple Myeloma

Cure Today featured Dr. Ang Li’s paper on risk factors for patients with Multiple Myeloma.

Cure Today
September 09, 2019

Weight loss possible with psychiatric drugs

Anne McTiernan provided expert commentary on a weight loss and psychiatric drug interaction study. 

Reuters
September 05, 2019

Weight loss possible with psychiatric drugs

Dr. Anne McTiernan provided expert commentary on a weight loss and psychiatric drug interaction study. 

Reuters
September 05, 2019

Low-Fat Dietary Pattern Offers Long-Term Health Benefits

HealthDay features Dr. Ross Prentice and the Women’s Health Initiative research on the benefits of long-term benefits of low-fat diets for 

HealthDay
September 04, 2019

Highlights from ASCO’s quality care symposium: A clinical trial may offer the best survival odds for people battling Non-Small-Cell Lung Cancer, but not enough patients enroll in them

Everyday Health highlights Dr. Cristina Merkhofer’s research on how clinical trial participation increases non-small-cell lung cancer survival times.

Everyday Health
September 04, 2019

Low-Fat Dietary Pattern Offers Long-Term Health Benefits

HealthDay features Dr. Ross Prentice and the Women’s Health Initiative research on the benefits of long-term benefits of low-fat diets for 

HealthDay
September 04, 2019

Highlights from ASCO’s quality care symposium: A clinical trial may offer the best survival odds for people battling Non-Small-Cell Lung Cancer, but not enough patients enroll in them

Everyday Health highlights Dr. Cristina Merkhofer’s research on how clinical trial participation increases non-small-cell lung cancer survival times.

Everyday Health
September 04, 2019

Paperwork, high costs could mean worse survival for lung cancer patients

HealthDay highlights Dr. Bernardo Goulart’s work on the impact of high out-pocket costs on the survival of lung cancer patients with certain mutations.  

HealthDay
September 03, 2019

Seeking Immunity: Exploring Kaposi’s Sarcoma

Dr. Thomas Uldrick provides expert commentary on Kaposi’s sarcoma- associated herpesvirus.

Cure Today
August 30, 2019

Seeking Immunity: Exploring Kaposi’s Sarcoma

Dr. Thomas Uldrick provides expert commentary on Kaposi’s sarcoma- associated herpesvirus.

Cure Today
August 30, 2019

CRISPR slows the growth of triple-negative breast cancer in mice

FierceBiotech references Fred Hutch research on the use of gold nanoparticles to deliver CRISPR edited cells to targeted areas.

FierceBiotech
August 26, 2019

CRISPR slows the growth of triple-negative breast cancer in mice

FierceBiotech references Fred Hutch research on the use of gold nanoparticles to deliver CRISPR edited cells to targeted areas.

FierceBiotech
August 26, 2019

Fred Hutch program inspires teens interested in science

KING 5 News profiled Fred Hutch’s Jeanne Ting Chowning and her work with the Pathway Explorers Program to educate and train the next-generation of scientists.

KING 5
August 21, 2019

What does your waist say about your health? According to a new study, a lot more than you’d think.

The Seattle Times features Dr. Marian Neuhouser’s research on body mass index, waist size and health correlates. 

The Seattle Times
August 21, 2019

Fred Hutch program inspires teens interested in science

KING 5 News profiled Fred Hutch’s Jeanne Ting Chowning and her work with the Pathway Explorers Program to educate and train the next-generation of scientists.

KING 5
August 21, 2019

What does your waist say about your health? According to a new study, a lot more than you’d think.

The Seattle Times features Dr. Marian Neuhouser’s research on body mass index, waist size and health correlates. 

The Seattle Times
August 21, 2019

Fred Hutch program inspires teens interested in science

KING 5 News profiled Fred Hutch’s Jeanne Ting Chowning and her work with the Pathway Explorers Program to educate and train the next-generation of scientists.

KING 5
August 21, 2019

What does your waist say about your health? According to a new study, a lot more than you’d think.

The Seattle Times features Dr. Marian Neuhouser’s research on body mass index, waist size and health correlates. 

The Seattle Times
August 21, 2019

NMSU and University of Washington students learn community health first-hand in rural NM

This article highlights the Health Disparities Field Experience, a 2-week immersive experience for University of Washington graduate students to travel to New Mexico and learn about health disparities in communities in the U.S Southwest. This was the first annual Health Disparities Field Experience sponsored by the Partnership for the Advancement of Cancer Research, a federally funded partnership between NMSU and Fred Hutch. .

New Mexico State News Center
August 16, 2019

NMSU and University of Washington students learn community health first-hand in rural NM

This article highlights the Health Disparities Field Experience, a 2-week immersive experience for University of Washington graduate students to travel to New Mexico and learn about health disparities in communities in the U.S Southwest. This was the first annual Health Disparities Field Experience sponsored by the Partnership for the Advancement of Cancer Research, a federally funded partnership between NMSU and Fred Hutch. .

New Mexico State News Center
August 16, 2019

NMSU and University of Washington students learn community health first-hand in rural NM

This article highlights the Health Disparities Field Experience, a 2-week immersive experience for University of Washington graduate students to travel to New Mexico and learn about health disparities in communities in the U.S Southwest. This was the first annual Health Disparities Field Experience sponsored by the Partnership for the Advancement of Cancer Research, a federally funded partnership between NMSU and Fred Hutch. .

New Mexico State News Center
August 16, 2019

NMSU and University of Washington students learn community health first-hand in rural NM

This article highlights the Health Disparities Field Experience, a 2-week immersive experience for University of Washington graduate students to travel to New Mexico and learn about health disparities in communities in the U.S Southwest. This was the first annual Health Disparities Field Experience sponsored by the Partnership for the Advancement of Cancer Research, a federally funded partnership between NMSU and Fred Hutch. .

New Mexico State News Center
August 16, 2019

Dr. John Hansen, who made marrow transplants safer, dies at 76

The New York Times highlights honored the late-Dr. John Hansen and his contributions to bone marrow transplant research. Note: Subscription required. 

The New York Times
August 13, 2019

Dr. John Hansen, who made marrow transplants safer, dies at 76

The New York Times highlights honored the late-Dr. John Hansen and his contributions to bone marrow transplant research. Note: Subscription required. 

The New York Times
August 13, 2019

Dr. John Hansen, who made marrow transplants safer, dies at 76

The New York Times highlights honored the late-Dr. John Hansen and his contributions to bone marrow transplant research. Note: Subscription required. 

The New York Times
August 13, 2019

Dr. John Hansen, who made marrow transplants safer, dies at 76

The New York Times highlights honored the late-Dr. John Hansen and his contributions to bone marrow transplant research. Note: Subscription required. 

The New York Times
August 13, 2019

Dense breast notification laws not leading to more screening ultrasounds

Reuters highlighted Dr. Christoph Lee’s study, which showed that despite state laws requiring women be notified of dense breast tissue, indicating higher cancer risk, this does not lead to increased screening ultrasound rates. 

Reuters
August 08, 2019

Dense breast notification laws not leading to more screening ultrasounds

Reuters highlighted Dr. Christoph Lee’s study, which showed that despite state laws requiring women be notified of dense breast tissue, indicating higher cancer risk, this does not lead to increased screening ultrasound rates. 

Reuters
August 08, 2019

Dense breast notification laws not leading to more screening ultrasounds

Reuters highlighted Dr. Christoph Lee’s study, which showed that despite state laws requiring women be notified of dense breast tissue, indicating higher cancer risk, this does not lead to increased screening ultrasound rates. 

Reuters
August 08, 2019

Dense breast notification laws not leading to more screening ultrasounds

Reuters highlighted Dr. Christoph Lee’s study, which showed that despite state laws requiring women be notified of dense breast tissue, indicating higher cancer risk, this does not lead to increased screening ultrasound rates. 

Reuters
August 08, 2019

Can an immune strategy used to treat cancer also wipe out HIV infections?

Hans-Peter Kiem provides expert commentary on the application of CART cell immunotherapy for HIV.

Science
August 07, 2019

Can an immune strategy used to treat cancer also wipe out HIV infections?

Hans-Peter Kiem provides expert commentary on the application of CART cell immunotherapy for HIV.

Science
August 07, 2019

Can an immune strategy used to treat cancer also wipe out HIV infections?

Hans-Peter Kiem provides expert commentary on the application of CART cell immunotherapy for HIV.

Science
August 07, 2019

Can an immune strategy used to treat cancer also wipe out HIV infections?

Hans-Peter Kiem provides expert commentary on the application of CAR T cell immunotherapy for HIV.

Science
August 07, 2019

Meet the 30 young leaders who are transforming the future of healthcare and disrupting a $3.5 trillion industry

Emily Silgard was chosen as one of Business Insider’s 30 under 40 awardees. This article highlights her efforts in leading a data science team at Fred Hutch. Note: Subscription required.

Business Insider
August 05, 2019

What we need to do to get more people with cancer into clinical trials

Dr. Joseph Unger provided expert commentary focused on clinical trial participation barriers.

Healthline
August 05, 2019

Meet the 30 young leaders who are transforming the future of healthcare and disrupting a $3.5 trillion industry

Emily Silgard was chosen as one of Business Insider’s 30 under 40 awardees. This article highlights her efforts in leading a data science team at Fred Hutch. Note: Subscription required.

Business Insider
August 05, 2019

What we need to do to get more people with cancer into clinical trials

Dr. Joseph Unger provided expert commentary focused on clinical trial participation barriers.

Healthline
August 05, 2019

Meet the 30 young leaders who are transforming the future of healthcare and disrupting a $3.5 trillion industry

Emily Silgard was chosen as one of Business Insider’s 30 under 40 awardees. This article highlights her efforts in leading a data science team at Fred Hutch. Note: Subscription required.

Business Insider
August 05, 2019

Meet the 30 young leaders who are transforming the future of healthcare and disrupting a $3.5 trillion industry

Emily Silgard was chosen as one of Business Insider’s 30 under 40 awardees. This article highlights her efforts in leading a data science team at Fred Hutch. Note: Subscription required.

Business Insider
August 05, 2019

What we need to do to get more people with cancer into clinical trials

Dr. Joseph Unger provided expert commentary focused on clinical trial participation barriers.

Healthline
August 05, 2019

Reversing sickle cell disease with CRISPR-edited stem cells

FierceBiotech highlights Hans-Peter Kiem’s research on the use of CRISPR to alter genes related to fetal hemoglobin production. 

FierceBiotech
July 31, 2019

Reversing sickle cell disease with CRISPR-edited stem cells

FierceBiotech highlights Hans-Peter Kiem’s research on the use of CRISPR to alter genes related to fetal hemoglobin production. 

FierceBiotech
July 31, 2019

Reversing sickle cell disease with CRISPR-edited stem cells

FierceBiotech highlights Hans-Peter Kiem’s research on the use of CRISPR to alter genes related to fetal hemoglobin production. 

FierceBiotech
July 31, 2019

Seattle mom turns the flight of her life into funds for cancer research

KING 5 News profiled Dr. Damian Green’s work on multiple myeloma with patient and fundraising advocate Sarah Kaufmann- Fink.  

KING 5
July 24, 2019

Seattle mom turns the flight of her life into funds for cancer research

KING 5 News profiled Dr. Damian Green’s work on multiple myeloma with patient and fundraising advocate Sarah Kaufmann- Fink.  

KING 5
July 24, 2019

Seattle mom turns the flight of her life into funds for cancer research

KING 5 News profiled Dr. Damian Green’s work on multiple myeloma with patient and fundraising advocate Sarah Kaufmann- Fink.  

KING 5
July 24, 2019

Ongoing study will examine cardiac toxicity of breast cancer treatment

Cure Today featured Kerryn Reding, a member of the UPBEAT study team, and their research on the cardiovascular effects of breast cancer.  

Cure Today
July 22, 2019

Ongoing study will examine cardiac toxicity of breast cancer treatment

Cure Today featured Kerryn Reding, a member of the UPBEAT study team, and their research on the cardiovascular effects of breast cancer.  

Cure Today
July 22, 2019

Gene found in embryos can cloak cancer from common immunotherapy methods, researchers find

GeekWire highlighted research led by Drs. Robert Bradley and Stephen Tapscott on how a gene normally found in early development, helps cancer cells avoid detection from the immune system. 

GeekWire
July 18, 2019

Gene found in embryos can cloak cancer from common immunotherapy methods, researchers find

GeekWire highlighted research led by Drs. Robert Bradley and Stephen Tapscott on how a gene normally found in early development, helps cancer cells avoid detection from the immune system. 

GeekWire
July 18, 2019

A’s Stephen Piscotty, the 2019 Hutch Award winner, on a mission to find cure for ALS after losing mother

The Seattle Times ran a feature on 2019 Hutch Award winner Stephen Piscotty.

The Seattle Times
July 16, 2019

A’s Stephen Piscotty, the 2019 Hutch Award winner, on a mission to find cure for ALS after losing mother

The Seattle Times ran a feature on 2019 Hutch Award winner Stephen Piscotty.

The Seattle Times
July 16, 2019

The Promise and price of cellular therapies

The July 22 issue of The New Yorker spotlights Fred Hutch’s pioneering research in bone marrow transplantation and how it led to cell therapies using a patient’s own cells. 

The New Yorker
July 15, 2019

The Promise and price of cellular therapies

The July 22 issue of The New Yorker spotlights Fred Hutch’s pioneering research in bone marrow transplantation and how it led to cell therapies using a patient’s own cells. 

The New Yorker
July 15, 2019

Microsoft joins with Pacific NW medical research institutions on data discovery platform

GeekWire covered the Cascadia Data Discovery Initiative, a new collaboration between Fred Hutch and Microsoft to create a shared network of research data. 

GeekWire
July 12, 2019

Microsoft joins with Pacific NW medical research institutions on data discovery platform

GeekWire covered the Cascadia Data Discovery Initiative, a new collaboration between Fred Hutch and Microsoft to create a shared network of research data. 

GeekWire
July 12, 2019

Fred Hutch appoints execs from Amazon and Celgene to board

The Puget Sound Business Journal covered the recent additions to the Fred Hutch board of directors. Sean Boyle from Amazon Web Services, and Dr. Corsee Sanders from Celgene will be added to the board. 

The Puget Sound Buisness Journal
July 10, 2019

Biopsies May Help Guide Treatment for Bladder Cancer

The Cancer Network analyzed Dr. Andrew Hsieh’s study on bladder cancer and rapid autopsies.

Cancer Network
July 10, 2019

Geeking out with a goal: Regina Wu brings Hutch research to classrooms

The Seattle Times profiled Regina Wu, a curriculum designer and educator at Fred Hutch, in its “Cool Jobs” feature.

The Seattle Times
July 10, 2019

Avoid these cancer-causing foods

Dr. Jeannette Schenk commented on what foods people should limit or avoid in order to reduce their cancer risk. 

U.S. News & World Report
July 10, 2019

Fred Hutch appoints execs from Amazon and Celgene to board

The Puget Sound Business Journal covered the recent additions to the Fred Hutch board of directors. Sean Boyle from Amazon Web Services, and Dr. Corsee Sanders from Celgene will be added to the board. 

The Puget Sound Buisness Journal
July 10, 2019

Biopsies May Help Guide Treatment for Bladder Cancer

The Cancer Network analyzed Dr. Andrew Hsieh’s study on bladder cancer and rapid autopsies.

Cancer Network
July 10, 2019

Geeking out with a goal: Regina Wu brings Hutch research to classrooms

The Seattle Times profiled Regina Wu, a curriculum designer and educator at Fred Hutch, in its “Cool Jobs” feature.

The Seattle Times
July 10, 2019

Avoid these cancer-causing foods

Dr. Jeannette Schenk commented on what foods people should limit or avoid in order to reduce their cancer risk. 

U.S. News & World Report
July 10, 2019

The Summer of Fred Hutch

Fred Hutch vice president Kelly O’Brien appeared on KING 5 News to discuss the community events Fred Hutch is organizing over the summer to fund cancer research.

KING 5
July 09, 2019

The Summer of Fred Hutch

Fred Hutch vice president Kelly O’Brien appeared on KING 5 News to discuss the community events Fred Hutch is organizing over the summer to fund cancer research.

KING 5
July 09, 2019

Why this cancer researcher (and survivor) is climbing Kilimanjaro to raise money to study cancer

GeekWire featured Dr. Kristin Anderson, a post-doctoral researcher at Fred Hutch who is climbing Mount Kilimanjaro this summer to raise money for Fred Hutch as part of the Climb to Fight Cancer fundraising effort. 

GeekWire
July 06, 2019

How Fred Hutchinson saved baseball in Seattle

Lookout Landing posted a profile of Fred Hutchinson and his legacy on the field and in the community

Lookout Landing
July 05, 2019

Stored in synapses: How scientists completed a map of the roundworm’s brain

Fred Hutch Dr. Aakanksha Singhvi provided expert commentary on recent research that shows a map the roundworm’s brain and what it means for understanding how brain controls behavior. 

The New York Times
July 03, 2019

Influx of Targeted Therapies Prompts Several Questions in AML Paradigms

OncLive profiled Dr. Mary-Beth Percival about her work using targeted agents to treat patients with acute myeloid leukemia. 

OncLive
July 02, 2019

Who was Fred Hutchinson?

KING 5 Evening aired a feature on Fred Hutchinson’s career and the legacy of his namesake cancer center. 

KING 5
June 28, 2019

Dr. Shadman on challenges with CAR T-cell therapy

Dr. Mazyar Shadman explains that one of the main challenges with CAR T-cell therapy is that there are an increasing number of CAR T-cell therapies, making it difficult for an effective product to stand out. 

OncLive
June 28, 2019

Hutch, the baseball hero and namesake for the cancer research center founded by his brother, was born in Seattle 100 years ago

The Seattle Times’ Pacific NW Magazine dedicated its “Now & Then” feature to Fred Hutchinson honoring what would have been his 100th birthday.

The Seattle Times
June 27, 2019

Lung cancer screening guidelines may miss more African Americans at risk

Dr. Jaimee Heffner provided expert commentary on a new study about lung cancer screening guidelines. This story was re-printed in several other outlets, including Business Insider. 

Reuters
June 27, 2019

Prostate cancer diagnosis may become easier with new urine test

Dr. Ruth Etzioni provided expert commentary about a new urine test to detect prostate cancer. 

Healthline
June 26, 2019

Cost effectiveness of CAR T-Cell therapy depends on long-term outcomes

Dr. Josh Roth provided expert commentary about a study on cost of CAR-T therapy.

Cancer Network
June 23, 2019

Concurrent ibrutinib with CAR T-Cell therapy improves ORR, reduces severe CRS in high-risk CLL

OncLive featured Dr. Jordan Gauthier’s study of a combination immunotherapy for patients with high risk- chronic lymphocytic leukemia (CLL). 

OncLive
June 21, 2019

Phase 1 study demonstrates safety of pembrolizumab in patients with HIV and advanced cancer

American Journal of Managed Care featured Dr. Tom Uldrick’s recent study showing that pembrolizumab is safe in cancer patients with HIV.

American Journal of Managed Care
June 18, 2019

HBV tied to non-liver digestive-tract cancers

MedPage Today highlighted a study led by Fred Hutch’s Dr. Scott Ramsey, which showed that newly diagnosed cancer patients were unaware that they were infected with Hepatitis B and other viruses.

MedPage Today
June 17, 2019

Disrupted gut microbiome promotes breast cancer spread in mice

Dr. Susan Bullman commented on a study about the gut microbiome and breast cancer. 

Forbes
June 11, 2019

Recruiting an Old Drug for a New Purpose in Battle Against Pediatric AML

Dr. Allison Kaeding is featured in a profile piece for her work on pediatric acute myeloid leukemia (AML). 

Oncology Times
June 06, 2019

CRISPR gene-edited babies may be at increased risk of early death, study finds

Fred Hutch Dr. Hans-Peter Kiem, director of the Stem Cell and Gene Therapy Program at Fred Hutch, provided expert commentary on a study about editing genes passed down to offspring. 

CNN
June 05, 2019

Listen: A special episode from the halls of the ASCO meeting

STAT interviewed Dr. Parth Shah on The Readout Loud podcast about his research on increasing HPV vaccination rates in the U.S. 

STAT
June 04, 2019

Genetic mutation that prevents HIV infection tied to earlier death

Dr. Hans-Peter Kiem provided expert commentary on a recent study showing that a genetic mutation of a gene that protects HIV infection is associated with earlier death.

The Scientist
June 03, 2019

Dr. Gary Gilliland on Fred Hutch and Washington commerce

United Airlines’ in-flight magazine interviewed Dr. Gary Gilliland to learn more about Fred Hutch’s work with Microsoft and Amazon to help advance cancer research. 

United Airlines Hemispheres Magazine
June 01, 2019

Local study asks, does a day's exercise fight breast cancer?

Dr. Anne McTiernan shared her expertise on exercise and cancer prevention in a segment that highlighted her new exercise study.

KOMO
May 31, 2019

Protecting against RSV

Reader’s Digest covered Dr. Justin Taylor’s recent study in Science Immunology on B cell engineering. 

Reader's Digest
May 29, 2019

OncLive honors 15 trailblazers with giants of cancer care program

OncLive included Dr. Fred Appelbaum as one of this year’s “Giants of Cancer Care” for his leukemia work. 

Oncology Times
May 28, 2019

Fred Hutchinson team uses gold nanoparticles to improve CRISPR gene editing

Fred Hutch Dr. Jennifer Adair’s recent research published in Nature Materials shows how to use a gold nanoparticle to deliver gene editing machinery to blood stem cells. 

FierceBiotech
May 27, 2019

Health claims in nutrition books can be a ‘volcano of nonsense.’ A new website is fighting back.

Dr. Mario Kratz provided comments on why he reviews the latest nutrition and health books for the Red Pen Reviews website. 

The Seattle Times
May 23, 2019

Historic steam plant in Seattle gets a fresh new look courtesy of Fred Hutch

GeekWire highlighted Fred Hutch’s recent developments to move into the historic Lake Union Steam Plant building. 

GeekWire
May 22, 2019

Piscotty honored as Hutch Award winner

MLB.com covered the news of Oakland A’s outfielder Stephen Piscotty winning the Hutch Award. The news was also published in the San Francisco Chronicle, NBC Sports Bay Area, and the San Jose Mercury News.

MLB.com
May 21, 2019

Genetically engineered immune cells fight off deadly virus in mice

Science covered a B cell engineering study led by Dr. Justin Taylor. 

Science
May 17, 2019

Researchers use gene editing to make cells immune to HIV and other infections in Fred Hutch study

GeekWire covered Fred Hutch Dr. Justin Taylor’s recent work using gene editing to protect against HIV and other viruses. 

GeekWire
May 17, 2019

Seattle skyline to glow orange for National Cancer Research Month

King 5 highlighted Fred Hutch’s ‘Glow Orange to Cure Cancer’ campaign, a week-long campaign where Seattle landmarks and businesses glowed orange for a week in May in honor of National Cancer Research month. 

KING 5
May 07, 2019

Does sleep apnea cause cancer? New evidence suggests women could be at more risk

Dr Amanda Phipps, was interviewed by Survivornet about the association of sleep apnea and cancer risk.

Survivornet
May 06, 2019

Study highlights challenges in using artificial intelligence to personalize cancer treatment

STAT covered Dr. Bernardo Goulart’s study on using artificial intelligence to identify certain lung cancer patients. 

STAT
May 06, 2019

Algorithms help spot cancer ‘lottery winners’ in new Fred Hutch study

GeekWire profiled Fred Hutch Dr. Bernardo Goulart’s recent study on using artificial intelligence to identify lung cancer patients that have certain mutations. 

GeekWire
May 06, 2019

Recruiting an Old Drug for a New Purpose in Battle Against Pediatric AML

Dr. Allison Kaeding is featured in a profile piece for her work on pediatric acute myeloid leukemia (AML). 

Oncology Times
May 05, 2019

A new study links sugary drinks with disease. The reality is more complicated

The Seattle Times cited Dr. Mario Kratz about the health impact of sugary beverages.

The Seattle Times
May 01, 2019

Fred Hutch researchers map how bird flu jumps to humans

GeekWire covered Fred Hutch Dr. Jesse Bloom’s recent study looking at how the bird flu travels to humans. 

GeekWire
April 30, 2019

How you can climb the spire on top of the Space Needle

KING 5 aired a story on the Base 2 Space fundraising event that benefits Fred Hutch.

KING 5
April 26, 2019

Tech Moves: Madrona Venture Labs staffs up; Washington State Opportunity Scholarship executive director departs; and more

GeekWire highlighted Drs. Nancy Davidson and Denise Galloway recent induction into the Academy of Arts and Sciences, a scholarly society that began in 1780. 

GeekWire
April 23, 2019

High-deductible health policies linked to delayed diagnosis and treatment

Dr. Veena Shankaran, co-director of Fred Hutch’s health care and economics policy research group, the Hutchinson Institute for Cancer Outcomes Research, commented on the impact of high-deductible health plans on people with cancer. 

NPR
April 18, 2019

5' UTR mutations in prostate cancer

Ecancer, April 15, 2019

At the American Association for Cancer Research annual meeting, Fred Hutch Dr. Yiting Lim explained the 5’ UTR mutations that are present among the DNA of prostate cancer patients.

ECancer
April 15, 2019

5' UTR mutations in prostate cancer

At the American Association for Cancer Research annual meeting, Fred Hutch Dr. Yiting Lim explained the 5’ UTR mutations that are present among the DNA of prostate cancer patients.

ECancer
April 15, 2019

The disturbing links between too much weight and several types of cancer

Fred Hutch Dr. Jonathan Wright provided expert commentary on the relationship between excess weight and cancer risk. Dr. Wright is currently conducting a trial on overweight patients with low-grade, slow growing prostate cancer to see if monitoring their glucose levels through a weight loss period will improve their cancer outcomes.

The Washington Post
April 14, 2019

The disturbing links between too much weight and several types of cancer

Fred Hutch Dr. Jonathan Wright provided expert commentary on the relationship between excess weight and cancer risk. 

The Washington Post
April 14, 2019

A's Stephen Piscotty, Giants' Buster Posey nominated for Hutch Award

NBC Sports Bay Area profiled the nominees for the 54th annual Hutch Awards and how the honor represents the legacy of Fred Hutchinson.

NBC Sports Bay Area
April 09, 2019

A's Stephen Piscotty, Giants' Buster Posey nominated for Hutch Award

NBC Sports Bay Area profiled the nominees for the 54th annual Hutch Awards and how the honor represents the legacy of Fred Hutchinson.

NBC Sports Bay Area
April 09, 2019

Q&A: Epigenetic therapies for breast cancer

In this Q&A, Dr. Nancy E. Davidson, director of Fred Hutch’s Clinical Research Division and executive director and president of Seattle Cancer Care Alliance, discussed the latest breast cancer research and what has been learned so far in clinical trials for epigenetic therapies.

The Scientist
April 04, 2019

Q&A: Epigenetic therapies for breast cancer

In this Q&A, Dr. Nancy E. Davidson, director of Fred Hutch’s Clinical Research Division and executive director and president of Seattle Cancer Care Alliance, discussed the latest breast cancer research and what has been learned so far in clinical trials for epigenetic therapies.

The Scientist
April 04, 2019

Working Geek: Fred Hutch CIO Kathy Alexion shifts from ‘corporate soldier’ to mission driven

Fred Hutch CIO Kathy Alexion is profiled in this feature piece as GeekWire’s ‘Working Geek’.

GeekWire
March 15, 2019

Working Geek: Fred Hutch CIO Kathy Alexion shifts from ‘corporate soldier’ to mission driven

Fred Hutch CIO Kathy Alexion is profiled in this feature piece as GeekWire’s ‘Working Geek’.

GeekWire
March 15, 2019

Seattle Mayor Jenny Durkan promotes cancer research amid personal battle

KING 5 documented Seattle Mayor Jenny Durkan’s visit to Fred Hutch to discuss the future of cancer research in Seattle. 

King 5
March 13, 2019

Seattle’s only community lab puts a DIY spin on biotech

Regina Wu, who works in Fred Hutch’s Science Education Partnership program, is featured for her efforts in co-founding Seattle’s only community science lab.

Crosscut
March 13, 2019

Seattle Mayor Jenny Durkan promotes cancer research amid personal battle

KING 5 documented Seattle Mayor Jenny Durkan’s visit to Fred Hutch to discuss the future of cancer research in Seattle. 

King 5
March 13, 2019

Seattle’s only community lab puts a DIY spin on biotech

Regina Wu, who works in Fred Hutch’s Science Education Partnership program, is featured for her efforts in co-founding Seattle’s only community science lab.

Crosscut
March 13, 2019

Oral blood thinner may reduce blood clots in high-risk patients with cancer

CURE profiled Dr. Gary Lyman and a New England Journal of Medicine study he co-authored that evaluated a drug’s safety and efficacy in preventing blood clots in cancer patients. The results from this study, known as the CASSINI trial, showed that the drug may reduce the risk of blood clots in cancer patients.

Cure
March 08, 2019

Oral blood thinner may reduce blood clots in high-risk patients with cancer

CURE profiled Dr. Gary Lyman and a New England Journal of Medicine study he co-authored that evaluated a drug’s safety and efficacy in preventing blood clots in cancer patients. The results from this study, known as the CASSINI trial, showed that the drug may reduce the risk of blood clots in cancer patients.

Cure
March 08, 2019

An antibody-inspired small molecule could make for a better flu treatment

Fred Hutch’s Dr. Jesse Bloom commented on a study evaluating the early development of a new antiviral drug for influenza. He said, “We need more drugs in the fight against flu, and this approach could provide them."

NPR
March 07, 2019

An antibody-inspired small molecule could make for a better flu treatment

Fred Hutch’s Dr. Jesse Bloom commented on a study evaluating the early development of a new antiviral drug for influenza. He said, “We need more drugs in the fight against flu, and this approach could provide them."

NPR
March 07, 2019

Diversity in Science

Vishavjit Singh, a political cartoonist, performance artist and activist visited Fred Hutch to discuss how to confront biases and celebrate diversity and inclusion. This piece highlights his visit and the efforts at Fred Hutch to foster a supportive and inclusive scientific community. 

King 5
March 05, 2019

Second HIV patient may be cured after treatment

Dr. Hans-Peter Kiem, co-director of Fred Hutch’s HIV cure research program, provided insight around the second person who reportedly has been cured of HIV. 

HealthDay
March 05, 2019

London man seems to be free of HIV in second such case

Fred Hutch virologist Dr. Keith Jerome provided expert commentary about the second person who reportedly has been cured of HIV.

Associated Press
March 05, 2019

Diversity in Science

Vishavjit Singh, a political cartoonist, performance artist and activist visited Fred Hutch to discuss how to confront biases and celebrate diversity and inclusion. This piece highlights his visit and the efforts at Fred Hutch to foster a supportive and inclusive scientific community. 

King 5
March 05, 2019

Second HIV patient may be cured after treatment

Dr. Hans-Peter Kiem, co-director of Fred Hutch’s HIV cure research program, provided insight around the second person who reportedly has been cured of HIV. 

HealthDay
March 05, 2019

London man seems to be free of HIV in second such case

Fred Hutch virologist Dr. Keith Jerome provided expert commentary about the second person who reportedly has been cured of HIV.

Associated Press
March 05, 2019

Tobacco 21 and cancer consequences

KING 5 aired multiple stories on Dr. Jonathan Bricker’s efforts to help cancer patients quit smoking and to support the Washington state tobacco 21 bill which will raise the age of smoking from 18 to 21. The bill was signed into law at Fred Hutch on April 5th.

King 5
March 04, 2019

Ten years after the ‘Berlin patient,’ doctors announce a second person has been effectively ‘cured’ of HIV

Fred Hutch virologist Dr. Keith Jerome provided context around news of the second person who reportedly has been cured of HIV. He commented, “Now there’s not one, but two people that others living with HIV can look toward for encouragement.”

STAT
March 04, 2019

Tobacco 21 and cancer consequences

KING 5 aired multiple stories on Dr. Jonathan Bricker’s efforts to help cancer patients quit smoking and to support the Washington state tobacco 21 bill which will raise the age of smoking from 18 to 21. The bill was signed into law at Fred Hutch on April 5th.

King 5
March 04, 2019

Ten years after the ‘Berlin patient,’ doctors announce a second person has been effectively ‘cured’ of HIV

Fred Hutch virologist Dr. Keith Jerome provided context around news of the second person who reportedly has been cured of HIV. He commented, “Now there’s not one, but two people that others living with HIV can look toward for encouragement.”

STAT
March 04, 2019

From LA's 'Jungle' to the forefront of cancer research in Seattle

In this profile piece, Eric Nealy, a graduate research assistant in Dr. Jim Olson’s lab, discusses how with the help of his mom, his high school biology teacher, and the only African American science professor he could find at college helped him pursue a career in cancer research.

Crosscut
February 26, 2019

Hutchinson Institute for Cancer Outcomes Research names co-director

Dr. Veena Shankaran is profiled about her new role as the co-director of Hutchinson Institute for Cancer Outcomes Research. 

HemOnc Today
February 26, 2019

From LA's 'Jungle' to the forefront of cancer research in Seattle

In this profile piece, Eric Nealy, a graduate research assistant in Dr. Jim Olson’s lab, discusses how with the help of his mom, his high school biology teacher, and the only African American science professor he could find at college helped him pursue a career in cancer research.

Crosscut
February 26, 2019

Hutchinson Institute for Cancer Outcomes Research names co-director

Dr. Veena Shankaran is profiled about her new role as the co-director of Hutchinson Institute for Cancer Outcomes Research. 

HemOnc Today
February 26, 2019

Many newly diagnosed Patients with Cancer Are Unaware of Hepatitis Infection

This article features a recent study by Fred Hutch researcher Dr. Scott Ramsey published in JAMA Oncology which found that many cancer patients were had undiagnosed Hepatitis B and C and HIV infection.

CURE
February 25, 2019

Many newly diagnosed Patients with Cancer Are Unaware of Hepatitis Infection

This article features a recent study by Fred Hutch researcher Dr. Scott Ramsey published in JAMA Oncology which found that many cancer patients were had undiagnosed Hepatitis B and C and HIV infection.

CURE
February 25, 2019

Adding ibrutinib to CAR T-Cell therapy increases response rates in CLL

Dr. Jordan Gauthier explains his findings on a combination immunotherapy treatment. Gauthier and his team found that adding the targeted therapy drug ibrutinib to CAR T-cell therapy led to improved responses in patients with relapsed/refractory chronic lymphocytic leukemia.

Targeted Oncology,
February 22, 2019

Adding ibrutinib to CAR T-Cell therapy increases response rates in CLL

Dr. Jordan Gauthier explains his findings on a combination immunotherapy treatment. Gauthier and his team found that adding the targeted therapy drug ibrutinib to CAR T-cell therapy led to improved responses in patients with relapsed/refractory chronic lymphocytic leukemia.

Targeted Oncology,
February 22, 2019

Rivaroxaban decreases VTE incidence during intervention period among patients with cancer

This article features Dr. Gary Lyman’s recent research published in the New England Journal of Medicine. This was the first clinical study investigating the use of the direct oral anticoagulant, rivaroxaban, to prevent blood clots in patients with cancer at high-risk.

Healio
February 21, 2019

Rivaroxaban decreases VTE incidence during intervention period among patients with cancer

This article features Dr. Gary Lyman’s recent research published in the New England Journal of Medicine. This was the first clinical study investigating the use of the direct oral anticoagulant, rivaroxaban, to prevent blood clots in patients with cancer at high-risk.

Healio
February 21, 2019

Dormant tumor cells can be sensitized to chemotherapy

This blog post features Dr. Cyrus Ghajar’s latest work on metastatic breast cancer showing that dormant tumor cells can be sensitized to chemotherapy. 

National Cancer Institute
February 20, 2019

Dormant tumor cells can be sensitized to chemotherapy

This blog post features Dr. Cyrus Ghajar’s latest work on metastatic breast cancer showing that dormant tumor cells can be sensitized to chemotherapy. 

National Cancer Institute
February 20, 2019

Vaccines don’t work against some viruses. CRISPR might one day fix that

This article notes research led by Dr. Justin Taylor using CRISPR, a gene-editing tool, to fight viruses when vaccines can’t. Taylor explained how his team has been investigating CRISPR as a tool to edit B cells in mice that could synthesize antibodies against respiratory syncytial virus (RSV). 

STAT
February 19, 2019

Why do only eight percent of cancer patients in the U.S. participate in clinical trials?

This article features Dr. Joe Unger’s recent study on barriers to clinical trials. Unger’s study showed that structural and clinical barriers prevent more than 3 out of 4 cancer patients from participating in clinical trials.

Forbes
February 19, 2019

Next steps for CAR T cells in B-cell lymphomas

Dr. Victor Chow explains different treatment settings that CAR T-cell therapy is used in patients with B-cell lymphomas. He states that, “While CAR T cells have been approved for treatment of individuals after two or more lines of therapy, studies are now looking at moving this to the upfront setting.”

Targeted Oncology
February 19, 2019

Vaccines don’t work against some viruses. CRISPR might one day fix that

This article notes research led by Dr. Justin Taylor using CRISPR, a gene-editing tool, to fight viruses when vaccines can’t. Taylor explained how his team has been investigating CRISPR as a tool to edit B cells in mice that could synthesize antibodies against respiratory syncytial virus (RSV). 

STAT
February 19, 2019

Why do only eight percent of cancer patients in the U.S. participate in clinical trials?

This article features Dr. Joe Unger’s recent study on barriers to clinical trials. Unger’s study showed that structural and clinical barriers prevent more than 3 out of 4 cancer patients from participating in clinical trials.

Forbes
February 19, 2019

Next steps for CAR T cells in B-cell lymphomas

Dr. Victor Chow explains different treatment settings that CAR T-cell therapy is used in patients with B-cell lymphomas. He states that, “While CAR T cells have been approved for treatment of individuals after two or more lines of therapy, studies are now looking at moving this to the upfront setting.”

Targeted Oncology
February 19, 2019

Uncovering the enemy within

This article on new techniques to detect minimal residual disease includes expert commentary by Dr. Mary-Percival and highlights trials that are going on at Fred Hutch to examine personalized cell therapies for treating MRD in different blood cancers. 

CURE
February 13, 2019

Uncovering the enemy within

This article on new techniques to detect minimal residual disease includes expert commentary by Dr. Mary-Percival and highlights trials that are going on at Fred Hutch to examine personalized cell therapies for treating MRD in different blood cancers. 

CURE
February 13, 2019

Why gene editing may hold the promise of a herpes cure

Dr. Keith Jerome is featured in a story of research progress in treating herpes. He explains how his work with the gene editing tool – a class of enzymes called meganucleases – is showing more success in getting rid of the virus. 

Men’s Health
February 12, 2019

Why gene editing may hold the promise of a herpes cure

Dr. Keith Jerome is featured in a story of research progress in treating herpes. He explains how his work with the gene editing tool – a class of enzymes called meganucleases – is showing more success in getting rid of the virus. 

Men’s Health
February 12, 2019

Expert shares treatment options for localized muscle-invasive bladder cancer

Dr. Jonathan Wright discusses the available therapies for patients with localized muscle-invasive bladder cancer which include neoadjuvant chemotherapy, upfront cystectomy and immunotherapy. 

Targeted Oncology
February 11, 2019

Expert shares treatment options for localized muscle-invasive bladder cancer

Dr. Jonathan Wright discusses the available therapies for patients with localized muscle-invasive bladder cancer which include neoadjuvant chemotherapy, upfront cystectomy and immunotherapy. 

Targeted Oncology
February 11, 2019

Microsoft Healthcare reveals more of its strategy with new cloud and AI products for hospitals

GeekWire mentioned Fred Hutch’s work with Microsoft on helping cancer patients better track their treatment side effects.

GeekWire
February 07, 2019

Microsoft Healthcare reveals more of its strategy with new cloud and AI products for hospitals

GeekWire mentioned Fred Hutch’s work with Microsoft on helping cancer patients better track their treatment side effects.

GeekWire
February 07, 2019

An atlas of HIV’s ‘escape routes’ could improve vaccine design

This article features recent HIV research from Fred Hutch Drs. Jesse Bloom and Julie Overbaugh. Researchers have created an atlas of immune-evading mutations HIV mutations, providing insight on the functional interactions between antibodies and HIV. 

FierceBiotech
February 04, 2019

Tech moves: Dave Parker leaves Seven Peaks Ventures; Fred Hutch names a new CIO; and more

Kathy Alexion’s new role as Fred Hutch’s CIO was announced in GeekWire’s weekly tech moves column. Alexion previously supported former CIO Matthew Trunnell since 2016. 

GeekWire
February 04, 2019

Obesity triggering rising cancer rates in millennials

Fred Hutch researcher Stephen Schwartz provides expert commentary on a study published in The Lancet Public Health on obesity and cancer. 

Everyday Health
February 04, 2019

An atlas of HIV’s ‘escape routes’ could improve vaccine design

This article features recent HIV research from Fred Hutch Drs. Jesse Bloom and Julie Overbaugh. Researchers have created an atlas of immune-evading mutations HIV mutations, providing insight on the functional interactions between antibodies and HIV. 

FierceBiotech
February 04, 2019

Tech moves: Dave Parker leaves Seven Peaks Ventures; Fred Hutch names a new CIO; and more

Kathy Alexion’s new role as Fred Hutch’s CIO was announced in GeekWire’s weekly tech moves column. Alexion previously supported former CIO Matthew Trunnell since 2016. 

GeekWire
February 04, 2019

Obesity triggering rising cancer rates in millennials

Fred Hutch researcher  Dr. Stephen Schwartz provides expert commentary on a study published in The Lancet Public Health on obesity and cancer. 

Everyday Health
February 04, 2019

Five benefits of being an early riser

This article features research led by Fred Hutch researcher Dr. Anne McTiernan showing that women who exercised for 45 minutes in the morning 5 days a week reported 70 percent better sleep than before the study. 

The Guardian
February 03, 2019

Five benefits of being an early riser

This article features research led by Fred Hutch researcher Dr. Anne McTiernan showing that women who exercised for 45 minutes in the morning 5 days a week reported 70 percent better sleep than before the study. 

The Guardian
February 03, 2019

Tech moves: Rhapsody adds CCO as ‘Powered by Napster’ formally launches; DreamBox hires CFO following cash infusion; and more

Dr. Veena Shankaran’s new role as the co-director of Fred Hutch’s healthcare economics and policy group was announced in GeekWire’s weekly tech moves column. 

GeekWire
January 31, 2019

1st of its kind Seattle flu study aims to stop flu before it becomes pandemic

Fred Hutch Dr. Trevor Bedford comments on the value of the Seattle Flu Study.

KIRO
January 31, 2019

Tech moves: Rhapsody adds CCO as ‘Powered by Napster’ formally launches; DreamBox hires CFO following cash infusion; and more

Dr. Veena Shankaran’s new role as the co-director of Fred Hutch’s healthcare economics and policy group was announced in GeekWire’s weekly tech moves column. 

GeekWire
January 31, 2019

1st of its kind Seattle flu study aims to stop flu before it becomes pandemic

Fred Hutch Dr. Trevor Bedford comments on the value of the Seattle Flu Study.

KIRO
January 31, 2019

Seattle’s HIV Hope

Fred Hutch researcher Drs. Keith Jerome, Hans-Peter Kiem and Michael Louella, who coordinates the research group’s Community Advisory Board, provide expert comments on the importance of community engagement in HIV research. 

Cascadia Magazine
January 30, 2019

Seattle’s HIV Hope

Fred Hutch researcher Drs. Keith Jerome, Hans-Peter Kiem and Michael Louella, who coordinates the research group’s Community Advisory Board, provide expert comments on the importance of community engagement in HIV research. 

Cascadia Magazine
January 30, 2019

Healthy Living: Daily dose of exercise key woman living with stage 4 cancer

Fred Hutch researcher Dr. Anne McTiernan provided expert commentary on the value of exercise for those who have breast cancer. 

Q13 Fox
January 29, 2019

Healthy Living: Moderate exercise can reduce breast cancer risk 20%, research finds

Fred Hutch researcher Dr. Anne McTiernan is featured in this segment for her research on exercise in relation to breast cancer prevention. Dr. McTiernan found that moderate exercise, 45 minutes a day, 5 days a week, can reduce breast cancer risk by as much as 20%. 

Q13 Fox
January 29, 2019

Healthy Living: Daily dose of exercise key woman living with stage 4 cancer

Fred Hutch researcher Dr. Anne McTiernan provided expert commentary on the value of exercise for those who have breast cancer. 

Q13 Fox
January 29, 2019

Healthy Living: Moderate exercise can reduce breast cancer risk 20%, research finds

Fred Hutch researcher Dr. Anne McTiernan is featured in this segment for her research on exercise in relation to breast cancer prevention. Dr. McTiernan found that moderate exercise, 45 minutes a day, 5 days a week, can reduce breast cancer risk by as much as 20%. 

Q13 Fox
January 29, 2019

Information, not urgency, boosts parents’ confidence in HPV vaccine

This article features Fred Hutch researcher Dr. Parth Shah’s latest research on HPV vaccination. Dr. Shah found that parents were more confident in HPV vaccination and more motivated to have their child vaccinated by being exposed to physician messages that provided information rather than a sense of urgency. 

Reuters Health – MD Linx
January 28, 2019

Information, not urgency, boosts parents’ confidence in HPV vaccine

This article features Fred Hutch researcher Dr. Parth Shah’s latest research on HPV vaccination. Dr. Shah found that parents were more confident in HPV vaccination and more motivated to have their child vaccinated by being exposed to physician messages that provided information rather than a sense of urgency. 

Reuters Health – MD Linx
January 28, 2019

A Conversation with Gary Lyman, MD: Biosimilars and the Search for the Cure To Cancer Treatment’s Financial Toxicity

Fred Hutch researcher Dr. Gary Lyman is featured in this Q&A piece on biosimilars. Dr. Lyman provides comments about how the high prices of cancer treatment contribute to financial toxicity

Managed Care Online
January 25, 2019

Undiagnosed hepatitis common among people with cancer

This article highlights a recent study which found a high rate of undiagnosed acute and chronic hepatitis among cancer patients. Fred Hutch researcher Dr. Scott Ramsey provides expert commentary on the implications the study has in terms of screening. U.S. News & World Report also covered this study. 

POZ
January 25, 2019

A Conversation with Gary Lyman, MD: Biosimilars and the Search for the Cure To Cancer Treatment’s Financial Toxicity

Fred Hutch researcher Dr. Gary Lyman is featured in this Q&A piece on biosimilars. Dr. Lyman provides comments about how the high prices of cancer treatment contribute to financial toxicity

Managed Care Online
January 25, 2019

Undiagnosed hepatitis common among people with cancer

This article highlights a recent study which found a high rate of undiagnosed acute and chronic hepatitis among cancer patients. Fred Hutch researcher Dr. Scott Ramsey provides expert commentary on the implications the study has in terms of screening. U.S. News & World Report also covered this study. 

POZ
January 25, 2019

Got the flu? Seattle wants to swab your nose for a massive health data project

This story features the Seattle Flu Study, a new project from the Brotman Baty Institute which was co-founded by Seattle Children’s, UW Med and Fred Hutch. The study will look at 10,000 swabs to better understand how the flu spreads and how to prevent it. Fred Hutch’s Dr. Trevor Bedford is the lead data scientist for the study. 

GeekWire
January 23, 2019

What to eat – and how to feel better – during menopause

This article includes a mention of a Fred Hutch study led by Dr. Marian Neuhouser which found that women diagnosed with breast cancer who ate a low-fat diet were more likely to survive. 

The Seattle Times
January 23, 2019

Got the flu? Seattle wants to swab your nose for a massive health data project

This story features the Seattle Flu Study, a new project from the Brotman Baty Institute which was co-founded by Seattle Children’s, UW Med and Fred Hutch. The study will look at 10,000 swabs to better understand how the flu spreads and how to prevent it. Fred Hutch’s Dr. Trevor Bedford is the lead data scientist for the study. 

GeekWire
January 23, 2019

What to eat – and how to feel better – during menopause

This article includes a mention of a Fred Hutch study led by Dr. Marian Neuhouser which found that women diagnosed with breast cancer who ate a low-fat diet were more likely to survive. 

The Seattle Times
January 23, 2019

Scientists discover new potential way to stop breast cancer from spreading

Dr. Cyrus Ghajar’s latest research on metastatic breast cancer is the focus of this piece. Dr. Ghajar’s work details how to kill dormant breast cancer cells in their sleep. Several other outlets including GeekWire, KOMO-TV and FireceBiotech also covered this news.

Forbes
January 21, 2019

Scientists discover new potential way to stop breast cancer from spreading

Dr. Cyrus Ghajar’s latest research on metastatic breast cancer is the focus of this piece. Dr. Ghajar’s work details how to kill dormant breast cancer cells in their sleep. Several other outlets including GeekWire, KOMO-TV and FireceBiotech also covered this news.

Forbes
January 21, 2019

Lung transplant patients face elevated lung cancer risk

Fred Hutch Dr. Matthew Triplette’s recent research on lung cancer is featured in this piece. Dr. Triplette and his team showed that lung cancer risk was increased after lung transplantation, especially in the non-transplanted lung of single lung transplant recipients.

Ecancer
January 19, 2019

Lung transplant patients face elevated lung cancer risk

Fred Hutch Dr. Matthew Triplette’s recent research on lung cancer is featured in this piece. Dr. Triplette and his team showed that lung cancer risk was increased after lung transplantation, especially in the non-transplanted lung of single lung transplant recipients.

Ecancer
January 19, 2019

Medical ‘breakthrough’ may spell end of potentially toxic drugs in transplant recipients ABC News (Australia), Jan. 17, 2019

Dr. Geoffrey Hill and collaborators in Australia discovered how a common virus called cytomegalovirus reactivates in transplantation patients. In a study published in Science, the researchers found that strain-specific antibodies made from B cells are responsible for keeping CMV suppressed in mice, without the need for any other immune cells. 

ABC News
January 17, 2019

Medical ‘breakthrough’ may spell end of potentially toxic drugs in transplant recipients ABC News (Australia), Jan. 17, 2019

Dr. Geoffrey Hill and collaborators in Australia discovered how a common virus called cytomegalovirus reactivates in transplantation patients. In a study published in Science, the researchers found that strain-specific antibodies made from B cells are responsible for keeping CMV suppressed in mice, without the need for any other immune cells. 

ABC News
January 17, 2019

Comorbidities associated with lower clinical trial participation

This article features Dr. Joseph Unger’s recent study in JAMA Oncology on clinical trial participation. Dr. Unger shows that patients with comorbidities are less likely to participate in clinical trials.

CURE Today
January 16, 2019

Comorbidities associated with lower clinical trial participation

This article features Dr. Joseph Unger’s recent study in JAMA Oncology on clinical trial participation. Dr. Unger shows that patients with comorbidities are less likely to participate in clinical trials.

CURE Today
January 16, 2019

5 ways to protect your prostate

This piece highlights a study published in JNCI by Fred Hutch Dr. Joseph Unger, which shows that men who’ve taken 5-alpha reductase inhibitors had a 21 percent reduced risk of PCa 16 years later. 

Men’s Health
January 14, 2019

5 ways to protect your prostate

This piece highlights a study published in JNCI by Fred Hutch Dr. Joseph Unger, which shows that men who’ve taken 5-alpha reductase inhibitors had a 21 percent reduced risk of PCa 16 years later. 

Men’s Health
January 14, 2019

Geek of the Week: Fred Hutch’s Steve Pergam caught a ’bug’ for infectious diseases and research

Fred Hutch researcher Dr. Steve Pergam is featured as GeekWire’s ‘Geek of the Week’. Dr. Pergam is an associate member of the Vaccine and Infectious Disease Division at Fred Hutch. 
 

GeekWire
January 11, 2019

Cancer comorbidities reduce clinical trial participation, new SWOG study shows

Fred Hutch researcher Dr. Joseph Unger’s latest research on clinical trial participation is featured in this piece. Dr. Unger and his team showed that cancer patients with other illnesses or conditions, are less likely to be offered to join a clinical trial, and therefore less likely to enroll. This research was published in several other outlets including Healio, Medical Health News and MedPage Today. 

ecancer
January 11, 2019

Cancer comorbidities reduce clinical trial enrollment, study finds

This piece features Fred Hutch Dr. Joseph Unger’s latest research showing that expanding clinical trial eligibility criteria to allow patients with comorbidities would give opportunities for up to 6,317 cancer patients to be allowed to join a trial every year. 

Becker’s Hospital Review
January 11, 2019

Geek of the Week: Fred Hutch’s Steve Pergam caught a ’bug’ for infectious diseases and research

Fred Hutch researcher Dr. Steve Pergam is featured as GeekWire’s ‘Geek of the Week’. Dr. Pergam is an associate member of the Vaccine and Infectious Disease Division at Fred Hutch. 
 

GeekWire
January 11, 2019

Cancer comorbidities reduce clinical trial participation, new SWOG study shows

Fred Hutch researcher Dr. Joseph Unger’s latest research on clinical trial participation is featured in this piece. Dr. Unger and his team showed that cancer patients with other illnesses or conditions, are less likely to be offered to join a clinical trial, and therefore less likely to enroll. This research was published in several other outlets including Healio, Medical Health News and MedPage Today. 

ecancer
January 11, 2019

Cancer comorbidities reduce clinical trial enrollment, study finds

This piece features Fred Hutch Dr. Joseph Unger’s latest research showing that expanding clinical trial eligibility criteria to allow patients with comorbidities would give opportunities for up to 6,317 cancer patients to be allowed to join a trial every year. 

Becker’s Hospital Review
January 11, 2019

Cord blood transplantation provides ‘donor for every patient’

Fred Hutch Dr. Filippo Milano in featured in this Q&A piece about how cord blood is used for transplants. 

CURE Today
January 05, 2019

Cord blood transplantation provides ‘donor for every patient’

Fred Hutch Dr. Filippo Milano in featured in this Q&A piece about how cord blood is used for transplants. 

CURE Today
January 05, 2019

Fred Hutchinson bone barrow transplant program receives national recognition

Fred Hutch’s bone marrow transplant program at Seattle Cancer Care Alliance, the Hutch’s clinical care partner, received national recognition for its survival rates by the Center for International Blood and Marrow Transplant Research’s annual report.

Healio
December 29, 2018

Fred Hutchinson bone marrow transplant program receives national recognition

Fred Hutch’s bone marrow transplant program at Seattle Cancer Care Alliance, the Hutch’s clinical care partner, received national recognition for its survival rates by the Center for International Blood and Marrow Transplant Research’s annual report.

Healio
December 29, 2018

Knowledge of benefits, harms of medical marijuana for cancer ‘far from complete’

Fred Hutch researcher Dr. Steve Pergam comments on cannabis use among cancer patients.

Healio
December 25, 2018

Knowledge of benefits, harms of medical marijuana for cancer ‘far from complete’

Fred Hutch researcher Dr. Steve Pergam comments on cannabis use among cancer patients.

Healio
December 25, 2018

6 vitamin myths you have to stop believing – and 2 vitamins you actually do need

Fred Hutch Dr. Marian Neuhouser provides expert comments on the benefits of multivitamins.

MSN
December 22, 2018

The Allen Institute for Immunology

Dr. Gary Gilliland, Fred Hutch president and director, comments on the newly-announced Allen Institute for Immunology, which includes a research collaboration with Fred Hutch.

KING 5
December 13, 2018

The Allen Institute for Immunology

Dr. Gary Gilliland, Fred Hutch president and director, comments on the newly-announced Allen Institute for Immunology, which includes a research collaboration with Fred Hutch.

KING 5
December 13, 2018

Excess body weight responsible for 4% of cancers worldwide, study says

Fred Hutch Dr. Anne McTiernan provides expert commentary on a new study that found that excess body weight is responsible for 4% of cancer globally.

CNN
December 12, 2018

Biotech journalist Luke Timmerman sets his sights on Mount Kilimanjaro and $1M for cancer research

This article features Luke Timmerman, a local biotech journalist who is climbing Mount Kilimanjaro in July as a part of the Climb to Fight Cancer to raise money for Fred Hutch. After climbing Mount Everest in 2018, Timmerman raised $340,000 for cancer research. Timmerman now hopes to raise $850,00 with this climb.

GeekWire
December 12, 2018

Excess body weight responsible for 4% of cancers worldwide, study says

Fred Hutch Dr. Anne McTiernan provides expert commentary on a new study that found that excess body weight is responsible for 4% of cancer globally.

CNN
December 12, 2018

Biotech journalist Luke Timmerman sets his sights on Mount Kilimanjaro and $1M for cancer research

This article features Luke Timmerman, a local biotech journalist who is climbing Mount Kilimanjaro in July as a part of the Climb to Fight Cancer to raise money for Fred Hutch. After climbing Mount Everest in 2018, Timmerman raised $340,000 for cancer research. Timmerman now hopes to raise $850,00 with this climb.

GeekWire
December 12, 2018

Robust future ahead for stem cell transplants

Fred Hutch’s Dr. Geoffrey Hill provides expert commentary on stem cell transplantation in relation to CAR Ts.

OncLive
December 06, 2018

Robust future ahead for stem cell transplants

Fred Hutch’s Dr. Geoffrey Hill provides expert commentary on stem cell transplantation in relation to CAR Ts.

OncLive
December 06, 2018

Seattle-area health care chiefs debate cancer treatment costs and innovations

Fred Hutch Dr. Jim Olson provides expert commentary on the field of cancer care and research as a Seattle-area health care leader at a PSBJ health care event held earlier this month. Olson’s “tumor paint” technology is highlighted as a leading technology in the field of cancer care.

Puget Sound Business Journal
December 05, 2018

Amazon push into health data analytics inspires awe – and skepticism

This article highlights Fred Hutch’s work with Amazon on AWS’ Comprehend Medical Service. Matthew Trunnell provides expert commentary on the benefits of the service.

Politico
December 05, 2018

Seattle-area health care chiefs debate cancer treatment costs and innovations

Fred Hutch Dr. Jim Olson provides expert commentary on the field of cancer care and research as a Seattle-area health care leader at a PSBJ health care event held earlier this month. Olson’s “tumor paint” technology is highlighted as a leading technology in the field of cancer care.

Puget Sound Business Journal
December 05, 2018

Amazon push into health data analytics inspires awe – and skepticism

This article highlights Fred Hutch’s work with Amazon on AWS’ Comprehend Medical Service. Matthew Trunnell provides expert commentary on the benefits of the service.

Politico
December 05, 2018

CAR-T Cell Therapy combination shows promise in relapsed/refractor leukemia

This article features Fred Hutch Dr. Jordan Gauthier’s study findings presented at the 2018 ASH conference. His study shows that using chimeric antigen receptor (CAR)-T cell therapy plus Imbruvica, a targeted treatment, could improve outcomes in patients with relapsed or refractory chronic lymphocytic leukemia. Gauthier participated in an ASH press briefing and his work was covered by numerous other outlets including OncLive, Medpage Today, HemOnc Today, Targeted Oncology, and the Video Journal of Hematological Oncology.

CURE
December 04, 2018

CAR-T Cell Therapy combination shows promise in relapsed/refractor leukemia

This article features Fred Hutch Dr. Jordan Gauthier’s study findings presented at the 2018 ASH conference. His study shows that using chimeric antigen receptor (CAR)-T cell therapy plus Imbruvica, a targeted treatment, could improve outcomes in patients with relapsed or refractory chronic lymphocytic leukemia. Gauthier participated in an ASH press briefing and his work was covered by numerous other outlets including OncLive, Medpage Today, HemOnc Today, Targeted Oncology, and the Video Journal of Hematological Oncology.

CURE
December 04, 2018

Fred Hutch gala raises $10.4 million for cancer research, including $4 million from Microsoft

Fred Hutch’s 2018 annual holiday gala is featured for raising $10.4 million for cancer research.

Puget Sound Business Journal
December 03, 2018

Study identifies 40 new genetic variants associated with colorectal cancer risk

This article features the most comprehensive genome-wide association study of colorectal cancer risk to date, led by Dr. Ulrike “Riki” Peters. Peters and her team have discovered 40 new genetic variants associated with colorectal cancer risk.

Everyday Health
December 03, 2018

Fred Hutch gala raises $10.4 million for cancer research, including $4 million from Microsoft

Fred Hutch’s 2018 annual holiday gala is featured for raising $10.4 million for cancer research.

Puget Sound Business Journal
December 03, 2018

Study identifies 40 new genetic variants associated with colorectal cancer risk

This article features the most comprehensive genome-wide association study of colorectal cancer risk to date, led by Dr. Ulrike “Riki” Peters. Peters and her team have discovered 40 new genetic variants associated with colorectal cancer risk.

Everyday Health
December 03, 2018

Why should you care about Amazon’s new medical language processing service

Fred Hutch CIO Matthew Trunnell is quoted about how Fred Hutch is using Amazon’s new Comprehend Medical service.

Forbes
November 30, 2018

World AIDS Day

This segment, which aired on the eve of World AIDS Day, covers local and global HIV vaccine trials led by Fred Hutch. It includes interviews with Drs. Janine Maenza, Larry Corey and an HIV study vaccine participant.

KING 5
November 30, 2018

Amazon launches patient data-mining service to assist docs

This story details how Fred Hutch plans to utilize Amazon Comprehend Medical’s natural language processing capabilities and the benefits of doing so.

Computerworld
November 30, 2018

Why should you care about Amazon’s new medical language processing service

Fred Hutch CIO Matthew Trunnell is quoted about how Fred Hutch is using Amazon’s new Comprehend Medical service.

Forbes
November 30, 2018

World AIDS Day

This segment, which aired on the eve of World AIDS Day, covers local and global HIV vaccine trials led by Fred Hutch. It includes interviews with Drs. Janine Maenza, Larry Corey and an HIV study vaccine participant.

KING 5
November 30, 2018

Amazon launches patient data-mining service to assist docs

This story details how Fred Hutch plans to utilize Amazon Comprehend Medical’s natural language processing capabilities and the benefits of doing so.

Computerworld
November 30, 2018

Big tech expands footprint in health

This article mentions Fred Hutch's collaboration with Amazon Web Services on the new Comprehend Medical natural language processing service. Subscription required

The Wall Street Journal
November 27, 2018

Amazon unveils new service to mine and decode media records using artificial intelligence

Fred Hutch CIO Matthew Trunnell is quoted about how Fred Hutch is using Amazon’s new Comprehend Medical service.

GeekWire
November 27, 2018

Big tech expands footprint in health

This article mentions Fred Hutch's collaboration with Amazon Web Services on the new Comprehend Medical natural language processing service. Subscription required

The Wall Street Journal
November 27, 2018

Amazon unveils new service to mine and decode media records using artificial intelligence

Fred Hutch CIO Matthew Trunnell is quoted about how Fred Hutch is using Amazon’s new Comprehend Medical service.

GeekWire
November 27, 2018

Coping with head and neck cancer

Salene Jones, an assistant member in the Public Health Sciences Division at Fred Hutch, provides comments on depression screening for cancer patients in relation to a recent study that adds new information about suicide risk in head and neck cancer patients and survivors.

Cancer Today
November 21, 2018

Coping with head and neck cancer

Salene Jones, an assistant member in the Public Health Sciences Division at Fred Hutch, provides comments on depression screening for cancer patients in relation to a recent study that adds new information about suicide risk in head and neck cancer patients and survivors.

Cancer Today
November 21, 2018

Majority of HIV persistence during ART due to infected cell proliferation

This article features a recent study by Fred Hutch Drs. Dan Reeves and Josh Schiffer that shows that a majority of the HIV-infected cells that persist in HIV-infected individuals even during suppressive antiretroviral therapy (ART) originate from cellular proliferation, not viral replication.

Drug Target Review
November 20, 2018

Majority of HIV persistence during ART due to infected cell proliferation

This article features a recent study by Fred Hutch Drs. Dan Reeves and Josh Schiffer that shows that a majority of the HIV-infected cells that persist in HIV-infected individuals even during suppressive antiretroviral therapy (ART) originate from cellular proliferation, not viral replication.

Drug Target Review
November 20, 2018

Solving lymphoma’s stem-cell problem

Drs. Mary Flowers and Stephanie Lee provide expert comments on GvHD.

Nature
November 14, 2018

Solving lymphoma’s stem-cell problem

Drs. Mary Flowers and Stephanie Lee provide expert comments on GvHD.

Nature
November 14, 2018

Forbes 30 under 30: Healthcare

Alex Salter, a graduate student working in Stan Riddell's lab, made the Forbes 30 under 30 healthcare list for his work in immunotherapy.

Forbes
November 13, 2018

Forbes 30 under 30: Healthcare

Alex Salter, a graduate student working in Stan Riddell's lab, made the Forbes 30 under 30 healthcare list for his work in immunotherapy.

Forbes
November 13, 2018

It’s too early to take baby aspirin to cut ovarian cancer risk, but not too early to improve your diet

This article features research and comments by Dr. Marian Neuhouser on diet in relation to cancer prevention.

The Washington Post
November 12, 2018

It’s too early to take baby aspirin to cut ovarian cancer risk, but not too early to improve your diet

This article features research and comments by Dr. Marian Neuhouser on diet in relation to cancer prevention.

The Washington Post
November 12, 2018

How tech is unlocking a new way of thinking about health

Fred Hutch Dr. Elizabeth Krakow is featured in a recap of the personalized medicine panel at GeekWire's recent 2018 summit.

GeekWire
November 02, 2018

How tech is unlocking a new way of thinking about health

Fred Hutch Dr. Elizabeth Krakow is featured in a recap of the personalized medicine panel at GeekWire's recent 2018 summit.

GeekWire
November 02, 2018

Pricey precision medicine often financially toxic for cancer patients

Dr. Scott Ramsey and Dr. Gary Lyman provide expert comments on the cost of precision medicine and the impact it has on patients.

Kaiser Health News
November 01, 2018

Pricey precision medicine often financially toxic for cancer patients

Dr. Scott Ramsey and Dr. Gary Lyman provide expert comments on the cost of precision medicine and the impact it has on patients.

Kaiser Health News
November 01, 2018

Research finds 71 percent of tumors misidentified in children with rare cancer

This story summarizes a recent study by Dr. Jim Olson that shows 71 percent of tumors are misidentified in children with rare brain cancer due to limits in standard diagnostic methods.

KNKX-FM
October 25, 2018

Research finds 71 percent of tumors misidentified in children with rare cancer

This story summarizes a recent study by Dr. Jim Olson that shows 71 percent of tumors are misidentified in children with rare brain cancer due to limits in standard diagnostic methods.

KNKX-FM
October 25, 2018

Women Who Lead: Kelly O'Brien, mountaineer and philanthropy chief at Fred Hutch, aims high

This profile features Kelly O'Brien, vice president of philanthropy, in its Women Who Lead column that highlights “influential women leaders who are driving innovation and growth in the Puget Sound region."

Puget Sound Business Journal
October 19, 2018

Women Who Lead: Kelly O'Brien, mountaineer and philanthropy chief at Fred Hutch, aims high

This profile features Kelly O'Brien, vice president of philanthropy, in its Women Who Lead column that highlights “influential women leaders who are driving innovation and growth in the Puget Sound region."

Puget Sound Business Journal
October 19, 2018

The smaller the city, the bigger the flu epidemic

Dr. Trevor Bedford comments on a study that suggests that people living in smaller cities are more likely to face an intense outbreaks of seasonal flu during flu season.

Popular Science
October 18, 2018

The smaller the city, the bigger the flu epidemic

Dr. Trevor Bedford comments on a study that suggests that people living in smaller cities are more likely to face an intense outbreaks of seasonal flu during flu season.

Popular Science
October 18, 2018

Healthy Living: Doctors say exercise and diet can reduce risk of breast cancer

Dr. Anne McTiernan shares her top prevention tips during this breast cancer awareness month-focused interview.

KCPQ-TV
October 17, 2018

Healthy Living: Doctors say exercise and diet can reduce risk of breast cancer

Dr. Anne McTiernan shares her top prevention tips during this breast cancer awareness month-focused interview.

KCPQ-TV
October 17, 2018

The cancer that changed the course of Paul Allen’s life, and shaped his legacy

This story summarizes a recent study by Dr. Jim Olson that shows 71 percent of tumors are misidentified in children with rare brain cancer due to limits in standard diagnostic methods.

GeekWire
October 16, 2018

The cancer that changed the course of Paul Allen’s life, and shaped his legacy

This story summarizes Paul Allen's experience with cancer, featuring research by Dr. David Maloney. 

GeekWire
October 16, 2018

Fred Hutch president on Non-Hodgkin’s Lymphoma

Our president and director Gary Gilliland, explains non-Hodgkin Lymphoma.

KING-TV
October 15, 2018

Fred Hutch president on Non-Hodgkin’s Lymphoma

Our president and director Gary Gilliland, explains non-Hodgkin Lymphoma.

KING-TV
October 15, 2018

Childhood abuse may increase the risk of endometriosis, study finds

This story featured a study led by Fred Hutch epidemiologist Holly Harris which shows that women who reported severe or chronic childhood abuse were 79% more likely to have endometriosis.

HealthCentral
October 11, 2018

Childhood abuse may increase the risk of endometriosis, study finds

This story featured a study led by Fred Hutch epidemiologist Holly Harris which shows that women who reported severe or chronic childhood abuse were 79% more likely to have endometriosis.

HealthCentral
October 11, 2018

Seattle scientists lead the way on HIV vaccine research

KOMO featured Kristen Cohen and Ro Yoon in a story about a new HIV vaccine trial for which Fred Hutch is one of two sites.

KOMO News
October 10, 2018

Seattle scientists lead the way on HIV vaccine research

KOMO featured Kristen Cohen and Ro Yoon in a story about a new HIV vaccine trial for which Fred Hutch is one of two sites.

KOMO News
October 10, 2018

New HIV vaccine study will test first-of-its-kind tech, with backing from the Gates Foundation

GeekWire covered the launch of a new HIV vaccine trial for which Fred Hutch will serve as one of two sites.

GeekWire
October 09, 2018

New HIV vaccine study will test first-of-its-kind tech, with backing from the Gates Foundation

GeekWire covered the launch of a new HIV vaccine trial for which Fred Hutch will serve as one of two sites.

GeekWire
October 09, 2018

Ongoing Efforts Seek to Refine, Expand CAR T-Cell Therapy

Fred Hutch’s Dr. Brian Till shared his expertise on new developments in CAR T cell therapy.

OncLive
October 08, 2018

Ongoing Efforts Seek to Refine, Expand CAR T-Cell Therapy

Fred Hutch’s Dr. Brian Till shared his expertise on new developments in CAR T cell therapy.

OncLive
October 08, 2018

Breast Cancer: Everything you should know to keep it out of your future

Dr. Jennifer Specht shared her insights in diagnosing, treating and preventing breast cancer.

Prevention
October 01, 2018

Breast Cancer: Everything you should know to keep it out of your future

Dr. Jennifer Specht shared her insights in diagnosing, treating and preventing breast cancer.

Prevention
October 01, 2018

How one Fort Collins girl gave hope to 86,000 people with blood cancers

Dr. Fred Applebaum, the Hutch’s executive vice president and deputy director, commented about the recipient of the first unrelated donor transplant, that eventually led to the national match registry.

Coloradoan
September 27, 2018

Hyundai grant to Fred Hutch to help childhood leukemia research

This story focused on a $300k grant Dr. Roland Walter received from Hyundai. It included interviews with Dr. Walter & a pediatric cancer patient.

KIRO-TV
September 27, 2018

Hyundai grant to Fred Hutch to help childhood leukemia research

This story focused on a $300k grant Dr. Roland Walter received from Hyundai. It included interviews with Dr. Walter & a pediatric cancer patient.

KIRO-TV
September 27, 2018

How one Fort Collins girl gave hope to 86,000 people with blood cancers

Dr. Fred Applebaum, the Hutch’s executive vice president and deputy director, commented about the recipient of the first unrelated donor transplant, that eventually led to the national match registry.

Coloradoan
September 27, 2018

Hyundai grant to Fred Hutch to help childhood leukemia research

This story focused on a $300k grant Dr. Roland Walter received from Hyundai. It included interviews with Dr. Walter & a pediatric cancer patient.

KIRO-TV
September 27, 2018

Hyundai grant to Fred Hutch to help childhood leukemia research

This story focused on a $300k grant Dr. Roland Walter received from Hyundai. It included interviews with Dr. Walter & a pediatric cancer patient.

KIRO-TV
September 27, 2018

Should we rely on artificial intelligence to provide advice about cancer?

Dr. Scott Ramsey, director of Fred Hutch’s health economics group, talked about a partnership between the Hutch and Microsoft, using artificial intelligence technology to help cancer patients detect early, subtle signs of complications in an effort to improve patient health while lowering costs.

U.S. News & World Report
September 26, 2018

Should we rely on artificial intelligence to provide advice about cancer?

Dr. Scott Ramsey, director of Fred Hutch’s health economics group, talked about a partnership between the Hutch and Microsoft, using artificial intelligence technology to help cancer patients detect early, subtle signs of complications in an effort to improve patient health while lowering costs.

U.S. News & World Report
September 26, 2018

Fred Hutch study discovers how cancer evades immunotherapies, sometimes returning years later

Fred Hutch researchers Drs. Aude Chapuis and Kelly Paulson were quoted about their study identifying a potential cause for relapse in patients treated with immunotherapy for Merkel cell carcinoma, a skin cancer.

GeekWire
September 24, 2018

Fred Hutch study discovers how cancer evades immunotherapies, sometimes returning years later

Fred Hutch researchers Drs. Aude Chapuis and Kelly Paulson were quoted about their study identifying a potential cause for relapse in patients treated with immunotherapy for Merkel cell carcinoma, a skin cancer.

GeekWire
September 24, 2018

The Roots of Rural Health Disparities

This story summarized a study led by Dr. Joe Unger focused on outcomes for rural vs. urban cancer patients.

Cancer Today
September 13, 2018

Do bacteria cause stomach cancer?

This article mentions research by Fred Hutch’s Dr. Nina Salama and her team that identified a strain of Helicobacter pylori associated with stomach cancer.

Medical News Today
September 13, 2018

The Roots of Rural Health Disparities

This story summarized a study led by Dr. Joe Unger focused on outcomes for rural vs. urban cancer patients.

Cancer Today
September 13, 2018

Do bacteria cause stomach cancer?

This article mentions research by Fred Hutch’s Dr. Nina Salama and her team that identified a strain of Helicobacter pylori associated with stomach cancer.

Medical News Today
September 13, 2018

Fred Hutchinson and Seattle’s baseball renaissance of 1938

This historical feature about Fred Hutchinson's baseball career includes comments from Dr. Fred Appelbaum on how naming the Center in Hutchinson's honor keeps it tied to the Seattle community and culture.

KIRO-FM
September 12, 2018

What’s the likelihood that CRISPR will cure cancer?

Dr. Hans-Peter Kiem, director of Fred Hutch’s stem cell and gene therapy program, is featured in this article about CRISPR, a new gene-editing tool.

U.S. News & World Report
September 12, 2018

Fred Hutchinson and Seattle’s baseball renaissance of 1938

This historical feature about Fred Hutchinson's baseball career includes comments from Dr. Fred Appelbaum on how naming the Center in Hutchinson's honor keeps it tied to the Seattle community and culture.

KIRO-FM
September 12, 2018

What’s the likelihood that CRISPR will cure cancer?

Dr. Hans-Peter Kiem, director of Fred Hutch’s stem cell and gene therapy program, is featured in this article about CRISPR, a new gene-editing tool.

U.S. News & World Report
September 12, 2018

How glioblastoma is treated

In this CNN story, Fred Hutch’s Dr. Eric Holland said studies using targeted cancer therapies against glioblastoma have been unexpectedly disappointing.

CNN
August 25, 2018

How glioblastoma is treated

In this CNN story, Fred Hutch’s Dr. Eric Holland said studies using targeted cancer therapies against glioblastoma have been unexpectedly disappointing.

CNN
August 25, 2018

Overlooked molecule might be key to how well cancer-fighting CAR-T cells work

Lead author Alex Salter and senior author Dr. Stanley Riddell were quoted in this STAT article about a Fred Hutch study on co-stimulatory domain, a component of chimeric antigen receptor (CAR) T cells. Different co-stimulatory domains might affect safety and efficacy of these immunotherapies.

STAT
August 21, 2018

Overlooked molecule might be key to how well cancer-fighting CAR-T cells work

Lead author Alex Salter and senior author Dr. Stanley Riddell were quoted in this STAT article about a Fred Hutch study on co-stimulatory domain, a component of chimeric antigen receptor (CAR) T cells. Different co-stimulatory domains might affect safety and efficacy of these immunotherapies.

STAT
August 21, 2018

Teens in Fred Hutch program aspire to be scientists, doctors

Fred Hutch's Science Education Partnership program was featured in this story, focusing on a new training program for high school sophomores and juniors

The Daily Herald (Everett, Washington)
August 15, 2018

Teens in Fred Hutch program aspire to be scientists, doctors

Fred Hutch's Science Education Partnership program was featured in this story, focusing on a new training program for high school sophomores and juniors

The Daily Herald (Everett, Washington)
August 15, 2018

Colon cancer screening guidelines may need revising

This story cites new research led by Fred Hutch focused on the ideal age for men and women to receive their first colonoscopy screening.

Scientific American
August 14, 2018

Colon cancer screening guidelines may need revising

This story cites new research led by Fred Hutch focused on the ideal age for men and women to receive their first colonoscopy screening.

Scientific American
August 14, 2018

Maple Valley mom among growing number of millennials with colon cancer

Lauren Nudo, a stage 4 colon cancer patient, is featured in this story about the importance of awareness and raising money for cancer research.

KING-TV
August 10, 2018

Woman learns to bike to honor late father at Fred Hutch’s Obliteride

KING-TV newscasts provided extensive coverage of Fred Hutch’s Obliteride biking/walking fundraising event, including numerous stories about participants and their inspiration and motivation. This story profiled Smeeta Hirani and how she learned to ride a bike to honor her father, who died from lung cancer.

KING-TV
August 10, 2018

Maple Valley mom among growing number of millennials with colon cancer

Lauren Nudo, a stage 4 colon cancer patient, is featured in this story about the importance of awareness and raising money for cancer research.

KING-TV
August 10, 2018

Woman learns to bike to honor late father at Fred Hutch’s Obliteride

KING-TV newscasts provided extensive coverage of Fred Hutch’s Obliteride biking/walking fundraising event, including numerous stories about participants and their inspiration and motivation. This story profiled Smeeta Hirani and how she learned to ride a bike to honor her father, who died from lung cancer.

KING-TV
August 10, 2018

How this cancer therapy went from scientific underdog to potential cure

This GeekWire article and podcast weaves together Fred Hutch expertise in bone marrow transplantation and newer cell therapies, such as CAR T. The Hutch’s Dr. Stan Riddell and Dr. David Maloney talk about how CAR T-cell immunotherapy and how it was considered a crazy idea in the 1980s.

GeekWire
August 08, 2018

How this cancer therapy went from scientific underdog to potential cure

This GeekWire article and podcast weaves together Fred Hutch expertise in bone marrow transplantation and newer cell therapies, such as CAR T. The Hutch’s Dr. Stan Riddell and Dr. David Maloney talk about how CAR T-cell immunotherapy and how it was considered a crazy idea in the 1980s.

GeekWire
August 08, 2018

Opportunities, issues and challenges for biosimilars in oncology

In an article on the future of biosimilars, biologic agents that are highly similar but not identical to approved reference biologic agents, The ASCO Post quoted extensively from a recent article by the Hutch’s Dr. Gary Lyman and colleagues in The New England Journal of Medicine.

The ASCO Post
July 25, 2018

ASCO endorses guidelines for integrative therapies during and after breast cancer treatment

Fred Hutch’s Dr. Gary Lyman is quoted in this article announcing that the American Society of Clinical Oncology now accepts certain integrative therapies for patients and survivors of breast cancer. Lyman was co-chair of the ASCO panel reviewing the clinical practice guidelines.

The ASCO Post
July 25, 2018

Childhood abuse linked to endometriosis risk

Fred Hutch’s Dr. Holly Harris is quoted in this story about a study she authored on the association between childhood physical and sexual abuse and adulthood endometriosis.

Reuters
July 25, 2018

Opportunities, issues and challenges for biosimilars in oncology

In an article on the future of biosimilars, biologic agents that are highly similar but not identical to approved reference biologic agents, The ASCO Post quoted extensively from a recent article by the Hutch’s Dr. Gary Lyman and colleagues in The New England Journal of Medicine.

The ASCO Post
July 25, 2018

ASCO endorses guidelines for integrative therapies during and after breast cancer treatment

Fred Hutch’s Dr. Gary Lyman is quoted in this article announcing that the American Society of Clinical Oncology now accepts certain integrative therapies for patients and survivors of breast cancer. Lyman was co-chair of the ASCO panel reviewing the clinical practice guidelines.

The ASCO Post
July 25, 2018

Childhood abuse linked to endometriosis risk

Fred Hutch’s Dr. Holly Harris is quoted in this story about a study she authored on the association between childhood physical and sexual abuse and adulthood endometriosis.

Reuters
July 25, 2018

Top fundraisers from Base 2 Space climb given chance to climb to top of Space Needle mast

Jean Nelson, a top-10 “Base 2 Space” stair-climber in last year’s event, is among those who got to climb to the top of the Space Needle mast. “Base 2 Space” participants ascend the 832 stairs of Seattle’s landmark, and the latest event raised more than $860,000 for Fred Hutch research.

KIRO-TV
July 24, 2018

Fred Hutch program gives Washington science teachers a chance to hone their lab skills

This story profiles the experience of two high school science teachers, participating in Fred Hutch’s Science Education Partnership. The program pairs science teachers with Fred Hutch researchers to gain skills and expertise to bring into the classroom.

KNKX-FM
July 23, 2018

Is Station 31 making Seattle firefighters sick? Study hopes to find answers about ‘Cancer House’

Fred Hutch researchers are working with the city of Seattle to investigate whether firefighters at Station 31 have higher cancer rates than those at other stations. Designed to answer longstanding questions, the study is expected to conclude by summer 2019.

The Seattle Times
July 11, 2018

How does sleep influence cancer risk?

Dr. Amanda Phipps provided comment in this story, examining the links of sleep and cancer. Phipps notes “from a biological perspective, there are a lot of good reasons for us to suspect that insufficient sleep, chronic sleep debt or short sleep duration could have an impact on the development of cancer."

U.S. News & World Report
July 04, 2018

Fred Hutch study: Nanoparticles could help cutting-edge therapies get inside solid tumors

Fred Hutch researchers led by Dr. Matthias Stephan used nanoparticles to deliver two drugs directly into solid tumors to shut down the tumors’ defense mechanisms and rally the immune system. Although this was a preclinical study, not done in human patients, it opens the possibility that chimeric antigen receptor (CAR) T-cell therapies could be used not just in blood cancers but also in solid tumors. The drugs would precondition the patient and the tumor so the T cells would work better, Stephan said.

GeekWire
July 02, 2018

Fred Hutch report plots the nexus of cost and quality

This article published by Managed Care, focuses on the “Community Cancer Care in Washington State: Quality and Cost Report” recently released by the Hutch’s health care economics group, HICOR. “Committing to transparency as a catalyst for improvement, 27 hospital systems and cancer centers across Washington State bare all in the first public report to integrate clinic-level quality and cost data in oncology,” the article said.

Managed Care
July 02, 2018

Clinical trial inclusion, specialist collaboration can improve cancer outcomes for those with HIV

Drs. Jeffrey Schouten and Thomas Uldrick were interviewed for a cover story on HIV and cancer for Healio’s HemOnc Today. “How to prevent cancer in people with HIV and oncogenic viral infections, and how to diagnose the resultant cancers early so that treatment outcomes are improved, are important issues that need to be addressed for patients,” Schouten said.

Healio
June 26, 2018

Fred Hutch study finds genetic cause of aggressive brain cancer

Fred Hutch physician-scientist Dr. Eric Holland, senior vice president and director of the Human Biology Division, led a study that found that a subset of brain cancers called ependymomas can be traced back to a single, catastrophic mutation in a patient’s DNA. “It looks like a region of the DNA blew up,” he said. The GeekWire story also was reported on KIRO-TV.

GeekWire
June 26, 2018

Columnist shares dad’s story of long-term cancer survival

Jane Ann Morrison, a columnist with the Las Vegas Review-Journal, told readers that her 88-year-old father, Jim Morrison, a retired Boeing engineer who was diagnosed with non-Hodgkin lymphoma in 1991, was honored as a Hutch Hero at a June 14 Seattle Mariners game. “His bone marrow transplant at the center in 1993 has given my dad 25 additional years (and I predict even more),” she said.

Las Vegas Review
June 23, 2018

Two or more servings of red meat a week raises women’s risk of endometriosis by more than 50%

The U.K. newspaper Daily Mail, Yahoo! UK, ABC News Australia and other sites carried an article about Fred Hutch research published in the American Journal of Obstetrics and Gynecology suggesting that red meat intake increases estrogen levels, which can lead to endometriosis.

The Daily Mail
June 21, 2018

The Hutch’s 30-year journey to the Lake Union steam plant

Four days after the Hutch’s lease of the historic Lake Union steam plant was announced, real estate developer William Justen recounted the deal’s three-decade history.

Seattle Times
June 15, 2018

A leading oncology association says some complementary therapies helpful to women with breast cancer with HIV

Dr. Heather Greenlee, a Fred Hutch specialist in naturopathic medicine and integrative therapies, explained new guidelines adopted by the American Society of Clinical Oncology on the use of certain integrative approaches for managing symptoms and side effects of breast cancer treatment. She is a co-author of an article announcing the guidelines in the Journal of Clinical Oncology.

Everyday Health
June 14, 2018

‘Intersections of innovation:’ Madrona director Matt McIlwain named Fred Hutch chair as more tech execs join board

New Fred Hutch Board of Trustees chair Matt McIlwain and Fred Hutch COO Steve Stadum talk about the intersection of cancer research and technology. The story also notes the new additions of board members Allan Jones, president and CEO of the Allen Institute, and Lyft CFO Brian Roberts, a former high-ranking Microsoft executive.

GeekWire
June 08, 2018

External relations director for the HIV Vaccine Trial Network profiled

“The HIV epidemic is global and our research works to make sure our solutions reach those most vulnerable,” said Steven Wakefield, president of the Pride Foundation in a feature profile. Wakefield is external relations director for the HIV Vaccine Trial Network that is headquartered at the Hutch, where he established The Legacy Project to increase racial and ethnic involvement in clinical trials.

Puget Sound Business Journal
June 07, 2018

Will there ever be a vaccine against cancer?

Dr. Seth M. Pollack, a sarcoma expert at Fred Hutch, talks about the potential for – and the challenges in – creating vaccines to treat and prevent cancer. “There almost certainly is not a universal target. The vaccine has to tell the immune system to go find something specific, but there’s nothing specific that the immune system can look for that is common to all cancers,” he said, adding that “there are some targets that are expressed by lots of cancers.”

U.S. News & World Report
June 06, 2018

Fred Hutch breast cancer researcher says study will help many women avoid chemotherapy

Dr. Jennifer Specht, a Fred Hutch breast cancer researcher, appeared live on KING 5's "Take Five" news show to provide expert commentary on a new breast cancer treatment study.

KING-TV
June 06, 2018

Fred Hutch doctor comments on reducing need for breast cancer patients to undergo chemotherapy

Research presented at the American Society of Clinical Oncology (ASCO) and published in the New England Journal of Medicine suggests that new genetic testing may make it possible for 70 percent of early-stage breast cancer patients to avoid chemotherapy. Fred Hutch’s Dr. Kevin Cheung explained the study and its implications for patients.

KOMO-TV
June 04, 2018

The high cost of cancer treatment

Dr. Gary Lyman, co-director of the Hutch’s health economics group, HICOR, was quoted extensively in an AARP article on financial toxicity associated with cancer treatment. “Recent studies we’ve done have shown high rates of bankruptcy among patients with cancer. And this has escalated over the past decade, as some of the exciting new agents that have come along have just skyrocketed,” he said.

AARP Magazine
June 02, 2018

The high cost of cancer treatment

Dr. Gary Lyman, co-director of the Hutch’s health economics group, HICOR, was quoted extensively in an AARP article on financial toxicity associated with cancer treatment. “Recent studies we’ve done have shown high rates of bankruptcy among patients with cancer. And this has escalated over the past decade, as some of the exciting new agents that have come along have just skyrocketed,” he said.

AARP Magazine
June 02, 2018

Study presented at American Society of Clinical Oncology compares US and Canadian cancer care costs

Dr. Heather Greenlee, a Fred Hutch specialist in naturopathic medicine and integrative therapies, explained new guidelines adopted by the American Society of Clinical Oncology on the use of certain integrative approaches for managing symptoms and side effects of breast cancer treatment. She is a co-author of an article announcing the guidelines in the Journal of Clinical Oncology.

Reuters
June 01, 2018

Study presented at American Society of Clinical Oncology compares US and Canadian cancer care costs

Dr. Heather Greenlee, a Fred Hutch specialist in naturopathic medicine and integrative therapies, explained new guidelines adopted by the American Society of Clinical Oncology on the use of certain integrative approaches for managing symptoms and side effects of breast cancer treatment. She is a co-author of an article announcing the guidelines in the Journal of Clinical Oncology.

Reuters
June 01, 2018

New promise for bone-marrow transplants

Fred Hutch’s Dr. Stephanie Lee and Dr. Colleen Delaney are quoted in a feature story on companies striving to make bone-marrow transplants safer. Delaney explained an experimental therapy called NLA101 that was developed at Fred Hutch and then spun out as the company Nohla Therapeutics. Delaney is director of Fred Hutch’s cord-blood transplant program and founder and chief medical officer at Nohla. 

The Wall Street Journal
May 28, 2018

New promise for bone-marrow transplants

Fred Hutch’s Dr. Stephanie Lee and Dr. Colleen Delaney are quoted in a feature story on companies striving to make bone-marrow transplants safer. Delaney explained an experimental therapy called NLA101 that was developed at Fred Hutch and then spun out as the company Nohla Therapeutics. Delaney is director of Fred Hutch’s cord-blood transplant program and founder and chief medical officer at Nohla. 

The Wall Street Journal
May 28, 2018

Does eating soy products increase or lower risk of breast cancer?

Dr. Marian L. Neuhouser, head of the Cancer Prevention Program at Fred Hutch, discussed possible links between soy products and breast cancer. She noted compounds found in soybeans and other plants can mimic the effects of estrogen, a prime driver of most breast cancers, but most studies have found no negative association between soy consumption and breast cancer risk.

U.S. News & World Report
May 24, 2018

Seattle writer summits Mount Everest to raise money for Fred Hutch

KOMO News, GeekWire, KING-TV, KIRO-TV and other outlets covered the achievement of Seattle biotech writer Luke Timmerman, who reached the peak of Mount Everest on May 22 in his quest to raise funds for cancer research at Fred Hutch. Coverage continued through early June with interviews with Timmerman and recaps of his expedition on KING-TV, KOMO News, and KATU-TV. He has raised about $340,000 so far.

KOMO News
May 23, 2018

Seattle writer summits Mount Everest to raise money for Fred Hutch

KOMO News, GeekWire, KING-TV, KIRO-TV and other outlets covered the achievement of Seattle biotech writer Luke Timmerman, who reached the peak of Mount Everest on May 22 in his quest to raise funds for cancer research at Fred Hutch. Coverage continued through early June with interviews with Timmerman and recaps of his expedition on KING-TV, KOMO News, and KATU-TV. He has raised about $340,000 so far.

KOMO News
May 23, 2018

Cancer patients are twice as likely to declare bankruptcy

In an Associated Press story on the financial toll that cancer treatment can take, Fred Hutch’s Dr. Veena Shankaran, of the Hutch’s health economics group, HICOR, spoke about the financial struggles faced by cancer patients. She said, “A lot of times people don’t realize there are resources available until they’ve already gone broke.” The story appeared in the Chicago Tribune, The Seattle Times, at CBS News online and in numerous other outlets.

The Associated Press
May 22, 2018

Cancer patients are twice as likely to declare bankruptcy

In an Associated Press story on the financial toll that cancer treatment can take, Fred Hutch’s Dr. Veena Shankaran, of the Hutch’s health economics group, HICOR, spoke about the financial struggles faced by cancer patients. She said, “A lot of times people don’t realize there are resources available until they’ve already gone broke.” The story appeared in the Chicago Tribune, The Seattle Times, at CBS News online and in numerous other outlets.

The Associated Press
May 22, 2018

The Hutch closes in on a cancer cure

Dr. Gary Gilliland, president and director, and others at Fred Hutch are quoted in an in-depth feature on the institution’s history and day-to-day work, especially in cancer immunotherapy. “We’re curing people. The question is: Why aren’t we curing everybody, and how do we extend those curative methods to other types of cancers that have been more recalcitrant?” Gilliland said. The magazine also published a story behind the story. Coverage was picked up by Tacoma’s News Tribune and other outlets.

The Seattle Times, Pacific NW Magazine
May 17, 2018

The Hutch closes in on a cancer cure

Dr. Gary Gilliland, president and director, and others at Fred Hutch are quoted in an in-depth feature on the institution’s history and day-to-day work, especially in cancer immunotherapy. “We’re curing people. The question is: Why aren’t we curing everybody, and how do we extend those curative methods to other types of cancers that have been more recalcitrant?” Gilliland said. The magazine also published a story behind the story. Coverage was picked up by Tacoma’s News Tribune and other outlets.

The Seattle Times, Pacific NW Magazine
May 17, 2018

Fred Hutch president named “Geek of the Year”

Gary Gilliland, president and director of Fred Hutch was named “Geek of the Year” at the 2018 GeekWire Awards presentation. In selecting Gilliland for the prestigious award, GeekWire noted, “The nationally recognized cancer center is working on some of the hottest frontiers in cancer research, namely cellular immunotherapy treatments that specifically target a patient’s unique cancer mutations. Under Gilliland’s leadership, the Hutch has recruited big names from the technology field to its board of trustees, including Microsoft CEO Satya Nadella and Mike Clayville, a vice president at Amazon Web Services.” Mentioned as one of the most touching moments of the evening was when Gilliland asked his fellow nominees to share the stage with him.

GeekWire
May 10, 2018

Fred Hutch president named “Geek of the Year”

Gary Gilliland, president and director of Fred Hutch was named “Geek of the Year” at the 2018 GeekWire Awards presentation. In selecting Gilliland for the prestigious award, GeekWire noted, “The nationally recognized cancer center is working on some of the hottest frontiers in cancer research, namely cellular immunotherapy treatments that specifically target a patient’s unique cancer mutations. Under Gilliland’s leadership, the Hutch has recruited big names from the technology field to its board of trustees, including Microsoft CEO Satya Nadella and Mike Clayville, a vice president at Amazon Web Services.” Mentioned as one of the most touching moments of the evening was when Gilliland asked his fellow nominees to share the stage with him.

GeekWire
May 10, 2018

Artificial intelligence takes scientists inside living human cells

A 3D model of a living human cell – the newly unveiled Allen Integrated Cell – could help scientists solve many medical mysteries. Fred Hutch molecular biologist Roger Brent, who has been using the tool for several months, said, “This lets you see things with a simple microscope that are going to be helpful to researchers all over the world – including in less affluent places.”

NPR
May 09, 2018

Artificial intelligence takes scientists inside living human cells

A 3D model of a living human cell – the newly unveiled Allen Integrated Cell – could help scientists solve many medical mysteries. Fred Hutch molecular biologist Roger Brent, who has been using the tool for several months, said, “This lets you see things with a simple microscope that are going to be helpful to researchers all over the world – including in less affluent places.”

NPR
May 09, 2018

Experts have new advice on prostate cancer screening. Here’s why they put it back on the table

Ruth Etzioni, a biostatistician in the Public Health Sciences Division, commented on prostate cancer screening recommendations issued by the U.S. Preventive Services Task Force on how men can judge whether testing is right for them. “It means the benefits and harms of the decision are going to be different for different people. Screening might be a good decision for you, but your friend may come up with a different decision, she said. The LA Times article also appeared in The Seattle Times and other outlets.

Los Angeles Times
May 08, 2018

Experts have new advice on prostate cancer screening. Here’s why they put it back on the table

Ruth Etzioni, a biostatistician in the Public Health Sciences Division, commented on prostate cancer screening recommendations issued by the U.S. Preventive Services Task Force on how men can judge whether testing is right for them. “It means the benefits and harms of the decision are going to be different for different people. Screening might be a good decision for you, but your friend may come up with a different decision, she said. The LA Times article also appeared in The Seattle Times and other outlets.

Los Angeles Times
May 08, 2018

Microsoft partners with Fred Hutch to tackle chemotherapy side effects using new AI tech

Fred Hutch and Microsoft are working together to reduce the side effects of chemotherapy and the emergency room visits that result. “They’ve unveiled a new pilot program that will leverage Microsoft’s artificial intelligence technology and Fred Hutch’s clinical and data science expertise,” said a story in GeekWire. The story also appeared on KIRO-TV.

GeekWire
May 07, 2018

Microsoft partners with Fred Hutch to tackle chemotherapy side effects using new AI tech

Fred Hutch and Microsoft are working together to reduce the side effects of chemotherapy and the emergency room visits that result. “They’ve unveiled a new pilot program that will leverage Microsoft’s artificial intelligence technology and Fred Hutch’s clinical and data science expertise,” said a story in GeekWire. The story also appeared on KIRO-TV.

GeekWire
May 07, 2018

Seattle skyline to glows orange for Fred Hutch’s efforts to battle cancer

The Seattle Times noted that landmarks across Seattle would glow orange for several nights during the week of May 7 to bring attention to Fred Hutch’s annual Obliteride bike ride that raises money to fight cancer. The event, which will be on Aug. 11, has brought in $12 million since it started. The story also was covered by KZJO-TV, KING-TV, KOMO-TV and KCPQ-TV.

The Seattle Times
May 04, 2018

Seattle skyline to glows orange for Fred Hutch’s efforts to battle cancer

The Seattle Times noted that landmarks across Seattle would glow orange for several nights during the week of May 7 to bring attention to Fred Hutch’s annual Obliteride bike ride that raises money to fight cancer. The event, which will be on Aug. 11, has brought in $12 million since it started. The story also was covered by KZJO-TV, KING-TV, KOMO-TV and KCPQ-TV.

The Seattle Times
May 04, 2018

Fred Hutch report aims to improve quality and costs of cancer care

Dr. Gary Gilliland, Fred Hutch president and director, was quoted in an article about the release of the Community Cancer Care in Washington State: Quality and Cost Report. “Participants in this endeavor can use it to learn where their efforts to improve quality and control costs are working most efficiently, and where they are not,” he said in a blog post, according to the article. The Hutchinson Institute for Cancer Outcomes Research worked on the report for five years, collecting data in partnership with providers and insurers.

Puget Sound Business Journal
May 03, 2018

Fred Hutch report aims to improve quality and costs of cancer care

Dr. Gary Gilliland, Fred Hutch president and director, was quoted in an article about the release of the Community Cancer Care in Washington State: Quality and Cost Report. “Participants in this endeavor can use it to learn where their efforts to improve quality and control costs are working most efficiently, and where they are not,” he said in a blog post, according to the article. The Hutchinson Institute for Cancer Outcomes Research worked on the report for five years, collecting data in partnership with providers and insurers.

Puget Sound Business Journal
May 03, 2018

Gene editing shows promise in combating HIV reservoirs

FierceBiotech and other outlets reported on a study published by Drs. Christopher Peterson and Hans-Peter Kiem of the Fred Hutch Clinical Research Division about a gene editing technique studied in non-human primates that may one day help fight HIV in people.

FierceBiotech
April 20, 2018

Gene editing shows promise in combating HIV reservoirs

FierceBiotech and other outlets reported on a study published by Drs. Christopher Peterson and Hans-Peter Kiem of the Fred Hutch Clinical Research Division about a gene editing technique studied in non-human primates that may one day help fight HIV in people.

FierceBiotech
April 20, 2018

Fred Hutch researcher among scientists receiving new funding to map every cell in the body

The Chan Zuckerberg Initiative announced a new infusion of funding in support of scientists working on the Human Cell Atlas, including Fred Hutch researcher Raphael Gottardo, a member of the Vaccine and Infectious Disease Division and the Public Health Sciences Division. The project to map every cell in the human body is part of the $3 billion Chan Zuckerberg Initiative, the philanthropic organization of Facebook founder Mark Zuckerberg and his wife Priscilla Chan, according to GeekWire.

GeekWire
April 19, 2018

Fred Hutch researcher among scientists receiving new funding to map every cell in the body

The Chan Zuckerberg Initiative announced a new infusion of funding in support of scientists working on the Human Cell Atlas, including Fred Hutch researcher Raphael Gottardo, a member of the Vaccine and Infectious Disease Division and the Public Health Sciences Division. The project to map every cell in the human body is part of the $3 billion Chan Zuckerberg Initiative, the philanthropic organization of Facebook founder Mark Zuckerberg and his wife Priscilla Chan, according to GeekWire.

GeekWire
April 19, 2018

CRISPR trials are about to begin in people — but we still don’t know how well it works in monkeys

Dr. Hans-Peter Kiem, a Fred Hutch oncologist, stem cell and gene therapy researcher, is quoted in this story about the gene-editing tool CRISPR, which may allow doctors to cure some diseases by altering a patient’s DNA. “Since monkeys are so similar to humans, I don’t think there’s going to be a huge challenge in translating this work to humans,” he said.

MIT Technology Review
April 11, 2018

CRISPR trials are about to begin in people — but we still don’t know how well it works in monkeys

Dr. Hans-Peter Kiem, a Fred Hutch oncologist, stem cell and gene therapy researcher, is quoted in this story about the gene-editing tool CRISPR, which may allow doctors to cure some diseases by altering a patient’s DNA. “Since monkeys are so similar to humans, I don’t think there’s going to be a huge challenge in translating this work to humans,” he said.

MIT Technology Review
April 11, 2018

Preventive benefit of finasteride for prostate cancer maintained for 16 years

A new study found that men who took finasteride for seven years had reduced risk for prostate cancer throughout 16 years of follow-up. “One concern with these kinds of interventions is that while people are taking the intervention that prostate cancer may be prevented, but then rates snap back once the intervention is discontinued. That did not happen here. The preventive benefit of finasteride was maintained over the 16 years,” said Dr. Joseph Unger, assistant member of the Cancer Prevention Program.

Cancer Therapy Advisor
April 09, 2018

Preventive benefit of finasteride for prostate cancer maintained for 16 years

A new study found that men who took finasteride for seven years had reduced risk for prostate cancer throughout 16 years of follow-up. “One concern with these kinds of interventions is that while people are taking the intervention that prostate cancer may be prevented, but then rates snap back once the intervention is discontinued. That did not happen here. The preventive benefit of finasteride was maintained over the 16 years,” said Dr. Joseph Unger, assistant member of the Cancer Prevention Program.

Cancer Therapy Advisor
April 09, 2018

News of Note—I-O in ovarian cancer; a single target for pain, obesity and depression

FierceBiotech highlighted work conducted by Dr. Kristin Anderson in Dr. Phil Greenberg’s lab on immunotherapy in ovarian cancer. The results, which were presented at the 2019 American Association for Cancer Research annual meeting showed that when combining engineered T cells with two other immune boosting treatments, the growth of ovarian tumors in mice was decreased.

FierceBiotech
April 01, 2018

News of Note—I-O in ovarian cancer; a single target for pain, obesity and depression

FierceBiotech highlighted work conducted by Dr. Kristin Anderson in Dr. Phil Greenberg’s lab on immunotherapy in ovarian cancer. The results, which were presented at the 2019 American Association for Cancer Research annual meeting showed that when combining engineered T cells with two other immune boosting treatments, the growth of ovarian tumors in mice was decreased.

FierceBiotech
April 01, 2018

It’s possible for women to have male DNA in their bodies, but there’s no need for alarm

A story that went viral in 2017 launched a wave of inaccurate stories about women acquiring male DNA from sexual partners. Not true, said Dr. J. Lee Nelson, a Fred Hutch autoimmunity researcher and rheumatologist. She explained that the most common source of male DNA in adult women is from prior pregnancy with a male child and how the mixing of DNA could benefit health.

INSIDER
March 28, 2018

It’s possible for women to have male DNA in their bodies, but there’s no need for alarm

A story that went viral in 2017 launched a wave of inaccurate stories about women acquiring male DNA from sexual partners. Not true, said Dr. J. Lee Nelson, a Fred Hutch autoimmunity researcher and rheumatologist. She explained that the most common source of male DNA in adult women is from prior pregnancy with a male child and how the mixing of DNA could benefit health.

INSIDER
March 28, 2018

Dr. Gary Lyman sees knowledge of biosimilars in cancer has improved

Fred Hutch Dr. Gary Lyman discussed the role of biosimilars and their growing use in cancer treatment.

American Journal of Managed Care
March 24, 2018

Dr. Gary Lyman sees knowledge of biosimilars in cancer has improved

Fred Hutch Dr. Gary Lyman discussed the role of biosimilars and their growing use in cancer treatment.

American Journal of Managed Care
March 24, 2018

Can we gene-edit herpes away?

Dr. Keith Jerome, a virologist at Fred Hutch, co-authored a 2016 study about gene editing in herpes-infected mice. “His is the first study to show that gene-editing technology can reach the latent virus in a nerve cell, and the first to use that technology to damage some of the virus’ DNA,” according to a Smithsonian.com article on this and other efforts to combat the virus in humans.

Smithsonian.com
March 23, 2018

Can we gene-edit herpes away?

Dr. Keith Jerome, a virologist at Fred Hutch, co-authored a 2016 study about gene editing in herpes-infected mice. “His is the first study to show that gene-editing technology can reach the latent virus in a nerve cell, and the first to use that technology to damage some of the virus’ DNA,” according to a Smithsonian.com article on this and other efforts to combat the virus in humans.

Smithsonian.com